{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T05:13:51Z","timestamp":1790140431741,"version":"4.0.1"},"reference-count":282,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T00:00:00Z","timestamp":1750118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T00:00:00Z","timestamp":1750118400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-025-06702-0","type":"journal-article","created":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T12:44:26Z","timestamp":1750164266000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["The roles of Cryptochrome-1: the circadian clock as a control point in cancer therapy"],"prefix":"10.1186","volume":"23","author":[{"given":"Yijia","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanzhe","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongliang","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueqin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,17]]},"reference":[{"issue":"3","key":"6702_CR1","doi-asserted-by":"publisher","first-page":"e13928","DOI":"10.1111\/apha.13928","volume":"237","author":"I Olejniczak","year":"2023","unstructured":"Olejniczak I, Begemann K, Wilhelm I, Oster H. The circadian neurobiology of reward. Acta Physiol. 2023;237(3):e13928.","journal-title":"Acta Physiol"},{"issue":"12","key":"6702_CR2","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1038\/nrm1766","volume":"6","author":"T Roenneberg","year":"2005","unstructured":"Roenneberg T, Merrow M. Circadian clocks \u2014 the fall and rise of physiology. Nat Rev Mol Cell Biol. 2005;6(12):965\u201371.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"14","key":"6702_CR3","doi-asserted-by":"publisher","first-page":"23978","DOI":"10.18632\/oncotarget.15074","volume":"8","author":"C Benna","year":"2017","unstructured":"Benna C, Helfrich-F\u00f6rster C, Rajendran S, Monticelli H, Pilati P, Nitti D, et al. Genetic variation of clock genes and cancer risk: a field synopsis and meta-analysis. Oncotarget. 2017;8(14):23978\u201395.","journal-title":"Oncotarget"},{"issue":"6451","key":"6702_CR4","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/366162a0","volume":"366","author":"M Ahmad","year":"1993","unstructured":"Ahmad M, Cashmore AR. HY4 gene of A. thaliana encodes a protein with characteristics of a blue-light photoreceptor. Nature. 1993;366(6451):162\u20136.","journal-title":"Nature"},{"issue":"6","key":"6702_CR5","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1562\/2005-07-08-IR-607","volume":"81","author":"CL Partch","year":"2005","unstructured":"Partch CL, Sancar A. Photochemistry and photobiology of Cryptochrome Blue-light photopigments: the search for a photocycle. Photochem Photobiol. 2005;81(6):1291\u2013304.","journal-title":"Photochem Photobiol"},{"key":"6702_CR6","doi-asserted-by":"crossref","unstructured":"Nie\u00dfner C, Denzau S, Malkemper EP, Gross JC, Burda H, Winklhofer M, et al. Cryptochrome 1 in retinal cone photoreceptors suggests a novel functional role in mammals. Sci Rep. 2016;6(1):21848.","DOI":"10.1038\/srep21848"},{"issue":"4","key":"6702_CR7","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/S0166-2236(99)01542-8","volume":"23","author":"KJ Lohmann","year":"2000","unstructured":"Lohmann KJ, Johnsen S. The neurobiology of magnetoreception in vertebrate animals. Trends Neurosci. 2000;23(4):153\u20139.","journal-title":"Trends Neurosci"},{"key":"6702_CR8","doi-asserted-by":"publisher","first-page":"3919","DOI":"10.2147\/IJN.S453265","volume":"19","author":"W Sun","year":"2024","unstructured":"Sun W, Xie S, Liu SF, Hu X, Xing D. Evolving tumor characteristics and smart nanodrugs for tumor immunotherapy. IJN. 2024;19:3919\u201342.","journal-title":"IJN"},{"issue":"22","key":"6702_CR9","doi-asserted-by":"publisher","first-page":"16484","DOI":"10.3390\/ijms242216484","volume":"24","author":"T Abaza","year":"2023","unstructured":"Abaza T, El-Aziz MKA, Daniel KA, Karousi P, Papatsirou M, Fahmy SA, et al. Emerging role of circular RNAs in hepatocellular carcinoma immunotherapy. Int J Mol Sci. 2023;24(22):16484.","journal-title":"Int J Mol Sci"},{"issue":"8","key":"6702_CR10","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1007\/s00432-014-1670-y","volume":"140","author":"HO El Mesallamy","year":"2014","unstructured":"El Mesallamy HO, Rashed WM, Hamdy NM, Hamdy N. High-dose methotrexate in Egyptian pediatric acute lymphoblastic leukemia: the impact of ABCG2 C421A genetic polymorphism on plasma levels, what is next? J Cancer Res Clin Oncol. 2014;140(8):1359\u201365.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"1","key":"6702_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s43018-019-0023-9","volume":"1","author":"The global challenge of cancer","year":"2020","unstructured":"The global challenge of cancer. Nat Cancer. 2020;1(1):1\u20132.","journal-title":"Nat Cancer"},{"issue":"10","key":"6702_CR12","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1158\/2159-8290.CD-20-0413","volume":"10","author":"M Pariollaud","year":"2020","unstructured":"Pariollaud M, Lamia KA. Cancer in the fourth dimension: what is the impact of circadian disruption?? Cancer Discov. 2020;10(10):1455\u201364.","journal-title":"Cancer Discov"},{"issue":"10","key":"6702_CR13","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1002\/bjs.1800561018","volume":"56","author":"T Hamilton","year":"1969","unstructured":"Hamilton T. Influence of environmental light and melatonin upon mammary tumour induction. Br J Surg. 1969;56(10):764\u20136.","journal-title":"Br J Surg"},{"issue":"6","key":"6702_CR14","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.4161\/cc.9.6.11046","volume":"9","author":"S Gery","year":"2010","unstructured":"Gery S, Koeffler HP. Circadian rhythms and cancer. Cell Cycle. 2010;9(6):1097\u2013103.","journal-title":"Cell Cycle"},{"issue":"5","key":"6702_CR15","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1111\/joim.12347","volume":"277","author":"C Dibner","year":"2015","unstructured":"Dibner C, Schibler U. Circadian timing of metabolism in animal models and humans. J Intern Med. 2015;277(5):513\u201327.","journal-title":"J Intern Med"},{"issue":"8","key":"6702_CR16","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1016\/S1470-2045(19)30455-3","volume":"20","author":"EM Ward","year":"2019","unstructured":"Ward EM, Germolec D, Kogevinas M, McCormick D, Vermeulen R, Anisimov VN, et al. Carcinogenicity of night shift work. Lancet Oncol. 2019;20(8):1058\u20139.","journal-title":"Lancet Oncol"},{"issue":"5","key":"6702_CR17","doi-asserted-by":"publisher","first-page":"479","DOI":"10.18632\/aging.100323","volume":"3","author":"EA Yu","year":"2011","unstructured":"Yu EA, Weaver DR. Disrupting the circadian clock: Gene-specific effects on aging, cancer, and other phenotypes. Aging. 2011;3(5):479\u201393.","journal-title":"Aging"},{"issue":"12","key":"6702_CR18","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1038\/s41591-018-0271-8","volume":"24","author":"S Masri","year":"2018","unstructured":"Masri S, Sassone-Corsi P. The emerging link between cancer, metabolism, and circadian rhythms. Nat Med. 2018;24(12):1795\u2013803.","journal-title":"Nat Med"},{"issue":"7","key":"6702_CR19","doi-asserted-by":"publisher","first-page":"870","DOI":"10.3109\/07420528.2013.782315","volume":"30","author":"N Cermakian","year":"2013","unstructured":"Cermakian N, Lange T, Golombek D, Sarkar D, Nakao A, Shibata S, et al. Crosstalk between the circadian clock circuitry and the immune system. Chronobiol Int. 2013;30(7):870\u201388.","journal-title":"Chronobiol Int"},{"key":"6702_CR20","doi-asserted-by":"publisher","first-page":"428122","DOI":"10.3389\/fendo.2019.00104","volume":"10","author":"S Morales-Santana","year":"2019","unstructured":"Morales-Santana S, Morell S, Leon J, Carazo-Gallego A, Jimenez-Lopez JC, Morell M. An overview of the polymorphisms of circadian genes associated with endocrine Cancer. Front Endocrinol. 2019;10:428122.","journal-title":"Front Endocrinol"},{"issue":"6098","key":"6702_CR21","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1126\/science.1223710","volume":"337","author":"T Hirota","year":"2012","unstructured":"Hirota T, Lee JW, St John PC, Sawa M, Iwaisako K, Noguchi T, et al. Identification of small molecule activators of Cryptochrome. Science. 2012;337(6098):1094\u20137.","journal-title":"Science"},{"issue":"10","key":"6702_CR22","doi-asserted-by":"publisher","first-page":"e0139725","DOI":"10.1371\/journal.pone.0139725","volume":"10","author":"X Tong","year":"2015","unstructured":"Tong X, Zhang D, Guha A, Arthurs B, Cazares V, Gupta N, et al. CUL4-DDB1-CDT2 E3 ligase regulates the molecular clock activity by promoting Ubiquitination-Dependent degradation of the mammalian CRY1. PLoS ONE. 2015;10(10):e0139725.","journal-title":"PLoS ONE"},{"issue":"58","key":"6702_CR23","doi-asserted-by":"publisher","first-page":"9043","DOI":"10.1038\/sj.onc.1205958","volume":"21","author":"CL Thompson","year":"2002","unstructured":"Thompson CL, Sancar A. Photolyase\/cryptochrome blue-light photoreceptors use photon energy to repair DNA and reset the circadian clock. Oncogene. 2002;21(58):9043\u201356.","journal-title":"Oncogene"},{"issue":"1","key":"6702_CR24","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/S1097-2765(03)00008-X","volume":"11","author":"R Brudler","year":"2003","unstructured":"Brudler R, Hitomi K, Daiyasu H, Toh H, Kucho K, ichi, Ishiura M, et al. Identification of a new Cryptochrome class: structure, function, and evolution. Mol Cell. 2003;11(1):59\u201367.","journal-title":"Mol Cell"},{"issue":"6","key":"6702_CR25","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1016\/j.cell.2013.05.011","volume":"153","author":"A Czarna","year":"2013","unstructured":"Czarna A, Berndt A, Singh HR, Grudziecki A, Ladurner AG, Timinszky G, et al. Structures of Drosophila Cryptochrome and mouse Cryptochrome1 provide insight into circadian function. Cell. 2013;153(6):1394\u2013405.","journal-title":"Cell"},{"key":"6702_CR26","doi-asserted-by":"crossref","unstructured":"Papp SJ, Huber AL, Jordan SD, Kriebs A, Nguyen M, Moresco JJ et al. DNA damage shifts circadian clock time via Hausp-dependent Cry1 stabilization. Takahashi JS, editor. eLife. 2015;4:e04883.","DOI":"10.7554\/eLife.04883"},{"issue":"9","key":"6702_CR27","doi-asserted-by":"publisher","first-page":"3602","DOI":"10.1096\/fj.12-203554","volume":"26","author":"J Richards","year":"2012","unstructured":"Richards J, Gumz ML. Advances in Understanding the peripheral circadian clocks. FASEB J. 2012;26(9):3602\u201313.","journal-title":"FASEB J"},{"issue":"2","key":"6702_CR28","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.neuron.2012.04.006","volume":"74","author":"Timing to Perfection","year":"2012","unstructured":"Timing to Perfection. The biology of central and peripheral circadian clocks. Neuron. 2012;74(2):246\u201360.","journal-title":"Neuron"},{"issue":"1","key":"6702_CR29","doi-asserted-by":"publisher","first-page":"7742","DOI":"10.1038\/s41598-023-34115-w","volume":"13","author":"D Marri","year":"2023","unstructured":"Marri D, Filipovic D, Kana O, Tischkau S, Bhattacharya S. Prediction of mammalian tissue-specific CLOCK\u2013BMAL1 binding to E-box DNA motifs. Sci Rep. 2023;13(1):7742.","journal-title":"Sci Rep"},{"issue":"6","key":"6702_CR30","doi-asserted-by":"publisher","first-page":"e12927","DOI":"10.1111\/eci.12927","volume":"48","author":"A Angelousi","year":"2018","unstructured":"Angelousi A, Kassi E, Nasiri-Ansari N, Weickert MO, Randeva H, Kaltsas G. Clock genes alterations and endocrine disorders. Eur J Clin Invest. 2018;48(6):e12927.","journal-title":"Eur J Clin Invest"},{"issue":"46","key":"6702_CR31","doi-asserted-by":"publisher","first-page":"35386","DOI":"10.1074\/jbc.M110.129288","volume":"285","author":"C Crumbley","year":"2010","unstructured":"Crumbley C, Wang Y, Kojetin DJ, Burris TP. Characterization of the core mammalian clock component, NPAS2, as a REV-ERB\u03b1\/ROR\u03b1 target gene**. J Biol Chem. 2010;285(46):35386\u201392.","journal-title":"J Biol Chem"},{"issue":"10","key":"6702_CR32","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1093\/abbs\/gmab105","volume":"53","author":"Lu Peng","year":"2021","unstructured":"Peng Lu, Bai G, Pang Y. Roles of NPAS2 in circadian rhythm and disease. Acta Biochim Biophys Sin. 2021;53(10):1257\u201365.","journal-title":"Acta Biochim Biophys Sin"},{"issue":"2","key":"6702_CR33","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/S0092-8674(00)81014-4","volume":"98","author":"K Kume","year":"1999","unstructured":"Kume K, Zylka MJ, Sriram S, Shearman LP, Weaver DR, Jin X, et al. mCRY1 and mCRY2 are essential components of the negative limb of the circadian clock feedback loop. Cell. 1999;98(2):193\u2013205.","journal-title":"Cell"},{"key":"6702_CR34","doi-asserted-by":"publisher","first-page":"3645","DOI":"10.2147\/OTT.S203144","volume":"12","author":"HX Li","year":"2019","unstructured":"Li HX. The role of circadian clock genes in tumors. OTT. 2019;123645\u201360.<\\\/p>","journal-title":"OTT"},{"issue":"46","key":"6702_CR35","doi-asserted-by":"publisher","first-page":"35386","DOI":"10.1074\/jbc.M110.129288","volume":"285","author":"C Crumbley","year":"2010","unstructured":"Crumbley C, Wang Y, Kojetin DJ, Burris TP. Characterization of the core mammalian clock component, NPAS2, as a REV-ERBalpha\/RORalpha target gene. J Biol Chem. 2010;285:(46):35386\u201392.","journal-title":"J Biol Chem"},{"issue":"1","key":"6702_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41420-024-01960-1","volume":"10","author":"Y Zeng","year":"2024","unstructured":"Zeng Y, Guo Z, Wu M, Chen F, Chen L. Circadian rhythm regulates the function of immune cells and participates in the development of tumors. Cell Death Discov. 2024;10(1):1\u201317.","journal-title":"Cell Death Discov"},{"issue":"8","key":"6702_CR37","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1038\/nrn1177","volume":"4","author":"MH Hastings","year":"2003","unstructured":"Hastings MH, Reddy AB, Maywood ES. A clockwork web: circadian timing in brain and periphery, in health and disease. Nat Rev Neurosci. 2003;4(8):649\u201361.","journal-title":"Nat Rev Neurosci"},{"key":"6702_CR38","doi-asserted-by":"crossref","unstructured":"Greene MW. Circadian rhythms and tumor growth. Cancer Lett. 2012 May 28;318(2):115\u201323.","DOI":"10.1016\/j.canlet.2012.01.001"},{"issue":"1","key":"6702_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.20892\/j.issn.2095-3941.2022.0474","volume":"20","author":"C Huang","year":"2023","unstructured":"Huang C, Zhang C, Cao Y, Li J, Bi F. Major roles of the circadian clock in cancer. Cancer Biology Med. 2023;20(1):1.","journal-title":"Cancer Biology Med"},{"key":"6702_CR40","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/978-1-4939-0888-2_2","volume":"1170","author":"KJ Barnum","year":"2014","unstructured":"Barnum KJ, O\u2019Connell MJ. Cell cycle regulation by checkpoints. Methods Mol Biol. 2014;1170:29\u201340.","journal-title":"Methods Mol Biol"},{"issue":"7918","key":"6702_CR41","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/s41586-022-04798-8","volume":"607","author":"S Basu","year":"2022","unstructured":"Basu S, Greenwood J, Jones AW, Nurse P. Core control principles of the eukaryotic cell cycle. Nature. 2022;607(7918):381\u20136.","journal-title":"Nature"},{"issue":"1","key":"6702_CR42","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41580-021-00404-3","volume":"23","author":"HK Matthews","year":"2022","unstructured":"Matthews HK, Bertoli C, de Bruin RAM. Cell cycle control in cancer. Nat Rev Mol Cell Biol. 2022;23(1):74\u201388.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"5","key":"6702_CR43","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.tcb.2018.01.006","volume":"28","author":"J Gaucher","year":"2018","unstructured":"Gaucher J, Montellier E, Sassone-Corsi P. Molecular cogs: interplay between circadian clock and cell cycle. Trends Cell Biol. 2018;28(5):368\u201379.","journal-title":"Trends Cell Biol"},{"issue":"42","key":"6702_CR44","doi-asserted-by":"publisher","first-page":"27039","DOI":"10.1074\/jbc.273.42.27039","volume":"273","author":"K Sakamoto","year":"1998","unstructured":"Sakamoto K, Nagase T, Fukui H, Horikawa K, Okada T, Tanaka H, et al. Multitissue circadian expression of rat periodhomolog (rPer2) mRNA is governed by the mammalian circadian clock, the Suprachiasmatic nucleus in the Brain *. J Biol Chem. 1998;273(42):27039\u201342.","journal-title":"J Biol Chem"},{"issue":"5643","key":"6702_CR45","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1126\/science.1086271","volume":"302","author":"T Matsuo","year":"2003","unstructured":"Matsuo T, Yamaguchi S, Mitsui S, Emi A, Shimoda F, Okamura H. Control mechanism of the circadian clock for timing of cell division in vivo. Science. 2003;302(5643):255\u20139.","journal-title":"Science"},{"issue":"5","key":"6702_CR46","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1016\/S0002-9440(10)64135-1","volume":"158","author":"GA Bjarnason","year":"2001","unstructured":"Bjarnason GA, Jordan RC, Wood PA, Li Q, Lincoln DW, Sothern RB, et al. Circadian expression of clock genes in human oral mucosa and skin: association with specific cell-cycle phases. Am J Pathol. 2001;158(5):1793\u2013801.","journal-title":"Am J Pathol"},{"issue":"5","key":"6702_CR47","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.cell.2005.06.028","volume":"122","author":"L Fu","year":"2005","unstructured":"Fu L, Patel MS, Bradley A, Wagner EF, Karsenty G. The molecular clock mediates leptin-regulated bone formation. Cell. 2005;122(5):803\u201315.","journal-title":"Cell"},{"issue":"21","key":"6702_CR48","doi-asserted-by":"publisher","first-page":"3788","DOI":"10.4161\/cc.10.21.17974","volume":"10","author":"E Destici","year":"2011","unstructured":"Destici E, Oklejewicz M, Saito S, van der Horst GTJ. Mammalian Cryptochromes impinge on cell cycle progression in a circadian clock-independent manner. Cell Cycle. 2011;10(21):3788\u201397.","journal-title":"Cell Cycle"},{"issue":"22","key":"6702_CR49","doi-asserted-by":"publisher","first-page":"5086","DOI":"10.1093\/nar\/26.22.5086","volume":"26","author":"K Kobayashi","year":"1998","unstructured":"Kobayashi K, Kanno S, Smit B, van der Horst GT, Takao M, Yasui A. Characterization of photolyase\/blue-light receptor homologs in mouse and human cells. Nucleic Acids Res. 1998;26(22):5086\u201392.","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"6702_CR50","doi-asserted-by":"publisher","first-page":"C311","DOI":"10.1152\/ajpcell.00256.2021","volume":"322","author":"R Kumar Sharma","year":"2022","unstructured":"Kumar Sharma R, Chafik A, Bertolin G. Mitochondrial transport, partitioning, and quality control at the heart of cell proliferation and fate acquisition. Am J Physiol Cell Physiol. 2022;322(2):C311\u201325.","journal-title":"Am J Physiol Cell Physiol"},{"issue":"2","key":"6702_CR51","doi-asserted-by":"publisher","first-page":"101","DOI":"10.3233\/NHA-160006","volume":"4","author":"A Chaudhari","year":"2017","unstructured":"Chaudhari A, Gupta R, Makwana K, Kondratov R. Circadian clocks, diets and aging. Nutr Healthy Aging. 2017;4(2):101\u201312.","journal-title":"Nutr Healthy Aging"},{"key":"6702_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbr.2013.05.028","volume":"252","author":"A Tapia-Osorio","year":"2013","unstructured":"Tapia-Osorio A, Salgado-Delgado R, Angeles-Castellanos M, Escobar C. Disruption of circadian rhythms due to chronic constant light leads to depressive and anxiety-like behaviors in the rat. Behav Brain Res. 2013;252:1\u20139.","journal-title":"Behav Brain Res"},{"issue":"1","key":"6702_CR53","doi-asserted-by":"publisher","first-page":"18614","DOI":"10.1038\/s41598-020-75245-9","volume":"10","author":"SL Chellappa","year":"2020","unstructured":"Chellappa SL, Morris CJ, Scheer FAJL. Circadian misalignment increases mood vulnerability in simulated shift work. Sci Rep. 2020;10(1):18614.","journal-title":"Sci Rep"},{"issue":"6","key":"6702_CR54","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.2337\/diabetes.50.6.1237","volume":"50","author":"SE la Fleur","year":"2001","unstructured":"la Fleur SE, Kalsbeek A, Wortel J, Fekkes ML, Buijs RM. A daily rhythm in glucose tolerance: A role for the Suprachiasmatic nucleus. Diabetes. 2001;50(6):1237\u201343.","journal-title":"Diabetes"},{"issue":"7378","key":"6702_CR55","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1038\/nature10700","volume":"480","author":"KA Lamia","year":"2011","unstructured":"Lamia KA, Papp SJ, Yu RT, Barish GD, Uhlenhaut NH, Jonker JW, et al. Cryptochromes mediate rhythmic repression of the glucocorticoid receptor. Nature. 2011;480(7378):552\u20136.","journal-title":"Nature"},{"issue":"2","key":"6702_CR56","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.cmet.2018.05.023","volume":"28","author":"M Toledo","year":"2018","unstructured":"Toledo M, Batista-Gonzalez A, Merheb E, Aoun ML, Tarabra E, Feng D, et al. Autophagy regulates the liver clock and glucose metabolism by degrading CRY1. Cell Metab. 2018;28(2):268\u2013e2814.","journal-title":"Cell Metab"},{"issue":"4","key":"6702_CR57","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1016\/j.bbrc.2015.11.054","volume":"468","author":"AM Mostafa","year":"2015","unstructured":"Mostafa AM, Hamdy NM, El-Mesallamy HO, Abdel-Rahman SZ. Glucagon-like peptide 1 (GLP-1)-based therapy upregulates LXR-ABCA1\/ABCG1 cascade in adipocytes. Biochem Biophys Res Commun. 2015;468(4):900\u20135.","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"6702_CR58","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s12881-017-0461-0","volume":"18","author":"MS Khella","year":"2017","unstructured":"Khella MS, Hamdy NM, Amin AI, El-Mesallamy HO. The (FTO) gene polymorphism is associated with metabolic syndrome risk in Egyptian females: a case- control study. BMC Med Genet. 2017;18(1):101.","journal-title":"BMC Med Genet"},{"issue":"1","key":"6702_CR59","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.cmet.2017.06.002","volume":"26","author":"SD Jordan","year":"2017","unstructured":"Jordan SD, Kriebs A, Vaughan M, Duglan D, Fan W, Henriksson E, et al. CRY1\/2 selectively repress PPAR\u03b4 and limit exercise capacity. Cell Metab. 2017;26(1):243\u2013e2556.","journal-title":"Cell Metab"},{"issue":"1","key":"6702_CR60","doi-asserted-by":"publisher","first-page":"12180","DOI":"10.1038\/ncomms12180","volume":"7","author":"H Jang","year":"2016","unstructured":"Jang H, Lee GY, Selby CP, Lee G, Jeon YG, Lee JH, et al. SREBP1c-CRY1 signalling represses hepatic glucose production by promoting FOXO1 degradation during refeeding. Nat Commun. 2016;7(1):12180.","journal-title":"Nat Commun"},{"key":"6702_CR61","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3389\/fendo.2014.00049","volume":"5","author":"G Griebel","year":"2014","unstructured":"Griebel G, Ravinet-Trillou C, Beesk\u00e9 S, Avenet P, Pichat P. Mice deficient in Cryptochrome 1 (Cry1\u2013\/\u2013) exhibit resistance to obesity induced by a High-Fat diet. Front Endocrinol (Lausanne). 2014;5:49.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"6702_CR62","doi-asserted-by":"publisher","first-page":"e5","DOI":"10.1017\/S1462399409000982","volume":"11","author":"SG Grant","year":"2009","unstructured":"Grant SG, Melan MA, Latimer JJ, Witt-Enderby PA. Melatonin and breast cancer: cellular mechanisms, clinical studies and future perspectives. Expert Rev Mol Med. 2009;11:e5.","journal-title":"Expert Rev Mol Med"},{"issue":"6","key":"6702_CR63","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.2174\/1570159X19666210907122933","volume":"20","author":"SY Sun","year":"2022","unstructured":"Sun SY, Chen GH. Treatment of circadian rhythm Sleep\u2013Wake disorders. Curr Neuropharmacol. 2022;20(6):1022\u201334.","journal-title":"Curr Neuropharmacol"},{"issue":"2","key":"6702_CR64","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1210\/edrv-12-2-151","volume":"12","author":"RJ Reiter","year":"1991","unstructured":"Reiter RJ. Pineal melatonin: cell biology of its synthesis and of its physiological interactions**. Endocr Rev. 1991;12(2):151\u201380.","journal-title":"Endocr Rev"},{"issue":"1","key":"6702_CR65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41398-023-02614-z","volume":"13","author":"D Yao","year":"2023","unstructured":"Yao D, Li R, Hao J, Huang H, Wang X, Ran L, et al. Melatonin alleviates depression-like behaviors and cognitive dysfunction in mice by regulating the circadian rhythm of AQP4 polarization. Transl Psychiatry. 2023;13(1):1\u201314.","journal-title":"Transl Psychiatry"},{"issue":"24","key":"6702_CR66","doi-asserted-by":"publisher","first-page":"39896","DOI":"10.18632\/oncotarget.16379","volume":"8","author":"Y Li","year":"2017","unstructured":"Li Y, Li S, Zhou Y, Meng X, Zhang JJ, Xu DP, et al. Melatonin for the prevention and treatment of cancer. Oncotarget. 2017;8(24):39896\u2013921.","journal-title":"Oncotarget"},{"key":"6702_CR67","doi-asserted-by":"crossref","unstructured":"Stehle JH, von Gall C, Korf HW. Melatonin: a clock-output, a clock-input. J Neuroendocrinol. 2003 Apr;15(4):383\u20139.","DOI":"10.1046\/j.1365-2826.2003.01001.x"},{"issue":"2","key":"6702_CR68","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/S0169-328X(03)00134-7","volume":"114","author":"H Dardente","year":"2003","unstructured":"Dardente H, Menet JS, Poirel VJ, Streicher D, Gauer F, Vivien-Roels B, et al. Melatonin induces Cry1 expression in the Pars tuberalis of the rat. Brain Res Mol Brain Res. 2003;114(2):101\u20136.","journal-title":"Brain Res Mol Brain Res"},{"key":"6702_CR69","doi-asserted-by":"crossref","unstructured":"Johnston JD, Tournier BB, Andersson H, Masson-P\u00e9vet M, Lincoln GA, Hazlerigg DG. Multiple effects of melatonin on rhythmic clock gene expression in the mammalian pars tuberalis. Endocrinology. 2006 Feb;147(2):959\u201365.","DOI":"10.1210\/en.2005-1100"},{"issue":"6","key":"6702_CR70","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1210\/me.2012-1366","volume":"27","author":"A West","year":"2013","unstructured":"West A, Dupr\u00e9 SM, Yu L, Paton IR, Miedzinska K, McNeilly AS, et al. Npas4 is activated by melatonin, and drives the clock gene Cry1 in the ovine Pars tuberalis. Mol Endocrinol. 2013;27(6):979\u201389.","journal-title":"Mol Endocrinol"},{"issue":"1","key":"6702_CR71","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-020-20513-5","volume":"12","author":"AA Shafi","year":"2021","unstructured":"Shafi AA, McNair CM, McCann JJ, Alshalalfa M, Shostak A, Severson TM, et al. The circadian cryptochrome, CRY1, is a pro-tumorigenic factor that rhythmically modulates DNA repair. Nat Commun. 2021;12(1):1\u201315.","journal-title":"Nat Commun"},{"issue":"12","key":"6702_CR72","doi-asserted-by":"publisher","first-page":"3376","DOI":"10.1111\/apa.16080","volume":"110","author":"L Pickering","year":"2021","unstructured":"Pickering L, Main KM, Feldt-Rasmussen U, Klose M, Sehested A, Mathiasen R, et al. Brain tumours in children and adolescents May affect the circadian rhythm and quality of life. Acta Paediatr. 2021;110(12):3376\u201386.","journal-title":"Acta Paediatr"},{"issue":"1","key":"6702_CR73","doi-asserted-by":"publisher","first-page":"151832","DOI":"10.1016\/j.acthis.2021.151832","volume":"124","author":"A Karimian","year":"2022","unstructured":"Karimian A, Mir Mohammadrezaei F, Hajizadeh Moghadam A, Bahadori MH, Ghorbani-Anarkooli M, Asadi A, et al. Effect of Astaxanthin and melatonin on cell viability and DNA damage in human breast cancer cell lines. Acta Histochem. 2022;124(1):151832.","journal-title":"Acta Histochem"},{"issue":"3","key":"6702_CR74","doi-asserted-by":"publisher","first-page":"151700","DOI":"10.1016\/j.acthis.2021.151700","volume":"123","author":"M Ghorbani-Anarkooli","year":"2021","unstructured":"Ghorbani-Anarkooli M, Dabirian S, Zendedel A, Moladoust H, Bahadori MH. Effects of melatonin on the toxicity and proliferation of human anaplastic thyroid cancer cell line. Acta Histochem. 2021;123(3):151700.","journal-title":"Acta Histochem"},{"issue":"5","key":"6702_CR75","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1002\/em.22087","volume":"58","author":"N Chatterjee","year":"2017","unstructured":"Chatterjee N, Walker GC. Mechanisms of DNA damage, repair and mutagenesis. Environ Mol Mutagen. 2017;58(5):235\u201363.","journal-title":"Environ Mol Mutagen"},{"issue":"22","key":"6702_CR76","doi-asserted-by":"publisher","first-page":"12254","DOI":"10.3390\/ijms222212254","volume":"22","author":"Kichi Yoshioka","year":"2021","unstructured":"Yoshioka Kichi, Kusumoto-Matsuo R, Matsuno Y, Ishiai M. Genomic instability and Cancer risk associated with erroneous DNA repair. Int J Mol Sci. 2021;22(22):12254.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"6702_CR77","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.3390\/cancers12041050","volume":"12","author":"JF Alhmoud","year":"2020","unstructured":"Alhmoud JF, Woolley JF, Al Moustafa AE, Malki MI. DNA damage\/repair management in cancers. Cancers (Basel). 2020;12(4):1050.","journal-title":"Cancers (Basel)"},{"key":"6702_CR78","doi-asserted-by":"crossref","unstructured":"Sancar A, Lindsey-Boltz LA, \u00dcnsal-Ka\u00e7maz K, Linn S. Molecular Mechanisms of Mammalian DNA Repair and the DNA Damage Checkpoints. Annu Rev Biochem. 2004;73:39\u201385..","DOI":"10.1146\/annurev.biochem.73.011303.073723"},{"issue":"7856","key":"6702_CR79","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1038\/s41586-021-03307-7","volume":"592","author":"B Schumacher","year":"2021","unstructured":"Schumacher B, Pothof J, Vijg J, Hoeijmakers JHJ. The central role of DNA damage in the ageing process. Nature. 2021;592(7856):695\u2013703.","journal-title":"Nature"},{"issue":"1","key":"6702_CR80","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.molmed.2015.11.007","volume":"22","author":"G Mazzoccoli","year":"2016","unstructured":"Mazzoccoli G, Laukkanen MO, Vinciguerra M, Colangelo T, Colantuoni V. A Timeless link between circadian patterns and disease. Trends Mol Med. 2016;22(1):68\u201381.","journal-title":"Trends Mol Med"},{"key":"6702_CR81","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.canlet.2017.05.022","volume":"402","author":"SL Liu","year":"2017","unstructured":"Liu SL, Lin HX, Lin CY, Sun XQ, Ye LP, Qiu F, et al. TIMELESS confers cisplatin resistance in nasopharyngeal carcinoma by activating the Wnt\/\u03b2-catenin signaling pathway and promoting the epithelial mesenchymal transition. Cancer Lett. 2017;402:117\u201330.","journal-title":"Cancer Lett"},{"issue":"7959","key":"6702_CR82","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/s41586-023-06009-4","volume":"617","author":"C Lin","year":"2023","unstructured":"Lin C, Feng S, DeOliveira CC, Crane BR. Cryptochrome\u2013Timeless structure reveals circadian clock timing mechanisms. Nature. 2023;617(7959):194\u20139.","journal-title":"Nature"},{"issue":"8","key":"6702_CR83","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.trecan.2019.07.002","volume":"5","author":"G Sulli","year":"2019","unstructured":"Sulli G, Lam MTY, Panda S. Interplay between circadian clock and cancer: new frontiers for cancer treatment. Trends Cancer. 2019;5(8):475\u201394.","journal-title":"Trends Cancer"},{"issue":"5b","key":"6702_CR84","first-page":"4347","volume":"23","author":"S Eissa","year":"2003","unstructured":"Eissa S, Swellam M, el-Mosallamy H, Mourad MS, Hamdy N\u039c, Kamel K, et al. Diagnostic value of urinary molecular markers in bladder cancer. Anticancer Res. 2003;23(5b):4347\u201355.","journal-title":"Anticancer Res"},{"issue":"17","key":"6702_CR85","doi-asserted-by":"publisher","first-page":"15349","DOI":"10.1007\/s00432-023-05313-w","volume":"149","author":"R Hammad","year":"2023","unstructured":"Hammad R, Eldosoky MA, Elmadbouly AA, Aglan RB, AbdelHamid SG, Zaky S, et al. Monocytes subsets altered distribution and dysregulated plasma hsa-miR-21-5p and hsa-miR-155-5p in HCV-linked liver cirrhosis progression to hepatocellular carcinoma. J Cancer Res Clin Oncol. 2023;149(17):15349\u201364.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"24","key":"6702_CR86","doi-asserted-by":"publisher","first-page":"7606","DOI":"10.1073\/pnas.80.24.7606","volume":"80","author":"GF Burns","year":"1983","unstructured":"Burns GF, Triglia T, Bartlett PF, Mackay IR. Human natural killer cells, activated lymphocyte killer cells, and monocytes possess similar cytotoxic mechanisms. Proc Natl Acad Sci U S A. 1983;80(24):7606\u201310.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6702_CR87","doi-asserted-by":"publisher","first-page":"403","DOI":"10.3389\/fimmu.2012.00403","volume":"3","author":"T Michel","year":"2013","unstructured":"Michel T, Hentges F, Zimmer J. Consequences of the crosstalk between monocytes\/macrophages and natural killer cells. Front Immunol. 2013;3:403.","journal-title":"Front Immunol"},{"issue":"1","key":"6702_CR88","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.immuni.2016.06.019","volume":"45","author":"S Wang","year":"2016","unstructured":"Wang S, Xia P, Chen Y, Huang G, Xiong Z, Liu J, et al. Natural Killer-like B cells prime innate lymphocytes against microbial infection. Immunity. 2016;45(1):131\u201344.","journal-title":"Immunity"},{"issue":"1","key":"6702_CR89","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.imlet.2014.11.014","volume":"163","author":"B Qin","year":"2015","unstructured":"Qin B, Deng Y. Overexpression of circadian clock protein Cryptochrome (CRY) 1 alleviates sleep deprivation-induced vascular inflammation in a mouse model. Immunol Lett. 2015;163(1):76\u201383.","journal-title":"Immunol Lett"},{"issue":"31","key":"6702_CR90","doi-asserted-by":"publisher","first-page":"12662","DOI":"10.1073\/pnas.1209965109","volume":"109","author":"R Narasimamurthy","year":"2012","unstructured":"Narasimamurthy R, Hatori M, Nayak SK, Liu F, Panda S, Verma IM. Circadian clock protein Cryptochrome regulates the expression of Proinflammatory cytokines. Proc Natl Acad Sci U S A. 2012;109(31):12662\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6702_CR91","doi-asserted-by":"publisher","first-page":"121997","DOI":"10.1016\/j.lfs.2023.121997","volume":"330","author":"MM Elanany","year":"2023","unstructured":"Elanany MM, Mostafa D, Hamdy NM. Remodeled tumor immune microenvironment (TIME) parade via natural killer cells reprogramming in breast cancer. Life Sci. 2023;330:121997.","journal-title":"Life Sci"},{"issue":"4","key":"6702_CR92","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1097\/JTO.0b013e3182037b76","volume":"6","author":"RM Bremnes","year":"2011","unstructured":"Bremnes RM, Al-Shibli K, Donnem T, Sirera R, Al-Saad S, Andersen S, et al. The role of tumor-Infiltrating immune cells and chronic inflammation at the tumor site on Cancer development, progression, and prognosis: emphasis on Non-small cell lung Cancer. J Thorac Oncol. 2011;6(4):824\u201333.","journal-title":"J Thorac Oncol"},{"issue":"3","key":"6702_CR93","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1038\/nri3386","volume":"13","author":"C Scheiermann","year":"2013","unstructured":"Scheiermann C, Kunisaki Y, Frenette PS. Circadian control of the immune system. Nat Rev Immunol. 2013;13(3):190\u20138.","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"6702_CR94","doi-asserted-by":"publisher","first-page":"1","DOI":"10.20892\/j.issn.2095-3941.2022.0474","volume":"20","author":"C Huang","year":"2023","unstructured":"Huang C, Zhang C, Cao Y, Li J, Bi F. Major roles of the circadian clock in cancer. Cancer Biol Med. 2023;20(1):1\u201324.","journal-title":"Cancer Biol Med"},{"issue":"15","key":"6702_CR95","doi-asserted-by":"publisher","first-page":"20574","DOI":"10.18632\/oncotarget.7827","volume":"7","author":"HX Li","year":"2016","unstructured":"Li HX, Fu XJ, Yang K, Chen D, Tang H, Zhao Q. The clock gene PER1 suppresses expression of tumor-related genes in human oral squamous cell carcinoma. Oncotarget. 2016;7(15):20574\u201383.","journal-title":"Oncotarget"},{"issue":"6","key":"6702_CR96","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1016\/j.mehy.2003.10.016","volume":"62","author":"LM Agius","year":"2004","unstructured":"Agius LM. The malignant transformation event as a clonal transformation of apoptosis to anti-apoptosis pathways and of cell cycle dynamics. Med Hypotheses. 2004;62(6):914\u20138.","journal-title":"Med Hypotheses"},{"issue":"6835","key":"6702_CR97","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1038\/35077213","volume":"411","author":"GI Evan","year":"2001","unstructured":"Evan GI, Vousden KH. Proliferation, cell cycle and apoptosis in cancer. Nature. 2001;411(6835):342\u20138.","journal-title":"Nature"},{"issue":"13","key":"6702_CR98","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.3390\/cells11132020","volume":"11","author":"MB Ahmed","year":"2022","unstructured":"Ahmed MB, Alghamdi AAA, Islam SU, Lee JS, Lee YS. cAMP signaling in cancer: A PKA-CREB and EPAC-Centric approach. Cells. 2022;11(13):2020.","journal-title":"Cells"},{"issue":"1","key":"6702_CR99","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/0896-6273(89)90116-5","volume":"3","author":"G Cadd","year":"1989","unstructured":"Cadd G, McKnight GS. Distinct patterns of cAMP-dependent protein kinase gene expression in mouse brain. Neuron. 1989;3(1):71\u20139.","journal-title":"Neuron"},{"issue":"1","key":"6702_CR100","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.bbrc.2017.05.041","volume":"500","author":"G Di Benedetto","year":"2018","unstructured":"Di Benedetto G, Gerbino A, Lefkimmiatis K. Shaping mitochondrial dynamics: the role of cAMP signalling. Biochem Biophys Res Commun. 2018;500(1):65\u201374.","journal-title":"Biochem Biophys Res Commun"},{"issue":"23","key":"6702_CR101","doi-asserted-by":"publisher","first-page":"9663","DOI":"10.1158\/0008-5472.CAN-08-2229","volume":"68","author":"X Deng","year":"2008","unstructured":"Deng X, Liu H, Huang J, Cheng L, Keller ET, Parsons SJ, et al. Ionizing radiation induces prostate cancer neuroendocrine differentiation through interplay of CREB and ATF2: implications for disease progression. Cancer Res. 2008;68(23):9663.","journal-title":"Cancer Res"},{"issue":"8","key":"6702_CR102","doi-asserted-by":"publisher","first-page":"2583","DOI":"10.1158\/1078-0432.CCR-08-1137","volume":"15","author":"KM Sakamoto","year":"2009","unstructured":"Sakamoto KM, Frank DA. CREB in the pathophysiology of cancer: implications for targeting transcription factors for cancer therapy. Clin Cancer Res. 2009;15(8):2583\u20137.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"6702_CR103","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s40164-020-00191-1","volume":"9","author":"H Zhang","year":"2020","unstructured":"Zhang H, Kong Q, Wang J, Jiang Y, Hua H. Complex roles of cAMP\u2013PKA\u2013CREB signaling in cancer. Experimental Hematol Oncol. 2020;9(1):32.","journal-title":"Experimental Hematol Oncol"},{"key":"6702_CR104","doi-asserted-by":"publisher","first-page":"106609","DOI":"10.1016\/j.domaniend.2021.106609","volume":"76","author":"SQ Zhao","year":"2021","unstructured":"Zhao SQ, Gao Y, Zhang Y, Yang XP, Yang Z. cAMP\/PKA\/CREB signaling pathway-mediated effects of melatonin receptor genes on clock gene expression in bactrian camel ovarian granulosa cells. Domest Anim Endocrinol. 2021;76:106609.","journal-title":"Domest Anim Endocrinol"},{"issue":"10","key":"6702_CR105","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1038\/nm.2214","volume":"16","author":"EE Zhang","year":"2010","unstructured":"Zhang EE, Liu Y, Dentin R, Pongsawakul PY, Liu AC, Hirota T, et al. Cryptochrome mediates circadian regulation of cAMP signaling and hepatic gluconeogenesis. Nat Med. 2010;16(10):1152\u20136.","journal-title":"Nat Med"},{"key":"6702_CR106","doi-asserted-by":"publisher","first-page":"111311","DOI":"10.1016\/j.cellsig.2024.111311","volume":"122","author":"D Chen","year":"2024","unstructured":"Chen D, Wang J, Cao J, Zhu G. cAMP-PKA signaling pathway and anxiety: where do we go next? Cell Signal. 2024;122:111311.","journal-title":"Cell Signal"},{"key":"6702_CR107","doi-asserted-by":"publisher","first-page":"1081030","DOI":"10.3389\/fphar.2023.1081030","volume":"14","author":"R Gao","year":"2023","unstructured":"Gao R, Zhang X, Zou K, Meng D, Lv J. Cryptochrome 1 activation inhibits melanogenesis and melanosome transport through negative regulation of cAMP\/PKA\/CREB signaling pathway. Front Pharmacol. 2023;14:1081030.","journal-title":"Front Pharmacol"},{"issue":"5","key":"6702_CR108","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1124\/mol.106.027029","volume":"70","author":"Q Ke","year":"2006","unstructured":"Ke Q, Costa M. Hypoxia-Inducible Factor-1 (HIF-1). Mol Pharmacol. 2006;70(5):1469\u201380.","journal-title":"Mol Pharmacol"},{"issue":"6","key":"6702_CR109","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.tips.2015.03.003","volume":"36","author":"G Peng","year":"2015","unstructured":"Peng G, Liu Y. Hypoxia-inducible factors in cancer stem cells and inflammation. Trends Pharmacol Sci. 2015;36(6):374\u201383.","journal-title":"Trends Pharmacol Sci"},{"issue":"16","key":"6702_CR110","doi-asserted-by":"publisher","first-page":"R921","DOI":"10.1016\/j.cub.2020.06.081","volume":"30","author":"NM Anderson","year":"2020","unstructured":"Anderson NM, Simon MC. The tumor microenvironment. Curr Biol. 2020;30(16):R921\u20135.","journal-title":"Curr Biol"},{"key":"6702_CR111","doi-asserted-by":"publisher","first-page":"942862","DOI":"10.3389\/fimmu.2022.942862","volume":"13","author":"H Wei","year":"2022","unstructured":"Wei H, Xie A, Li J, Fang C, Liu L, Xing J, et al. PD-1\u2009+\u2009CD4 T cell immune response is mediated by HIF-1\u03b1\/NFATc1 pathway after P. yoelii infection. Front Immunol. 2022;13:942862.","journal-title":"Front Immunol"},{"issue":"11","key":"6702_CR112","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.4251\/wjgo.v13.i11.1725","volume":"13","author":"Z Deng","year":"2021","unstructured":"Deng Z, Teng YJ, Zhou Q, Ouyang ZG, Hu YX, Long HP, et al. Shuyu pills inhibit immune escape and enhance chemosensitization in hepatocellular carcinoma. World J Gastrointest Oncol. 2021;13(11):1725\u201340.","journal-title":"World J Gastrointest Oncol"},{"issue":"1","key":"6702_CR113","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.cmet.2016.09.014","volume":"25","author":"Y Adamovich","year":"2017","unstructured":"Adamovich Y, Ladeuix B, Golik M, Koeners MP, Asher G. Rhythmic oxygen levels reset circadian clocks through HIF1\u03b1. Cell Metabol. 2017;25(1):93\u2013101.","journal-title":"Cell Metabol"},{"key":"6702_CR114","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.isci.2019.02.027","volume":"13","author":"EY Dimova","year":"2019","unstructured":"Dimova EY, Jakupovic M, Kubaichuk K, Mennerich D, Chi TF, Tamanini F, et al. The circadian clock protein CRY1 is a negative regulator of HIF-1\u03b1. iScience. 2019;13:284\u2013304.","journal-title":"iScience"},{"key":"6702_CR115","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.isci.2019.02.027","volume":"13","author":"The Circadian Clock","year":"2019","unstructured":"The Circadian Clock. Protein CRY1 is a negative regulator of HIF-1\u03b1. iScience. 2019;13:284\u2013304.","journal-title":"iScience"},{"issue":"1","key":"6702_CR116","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.gendis.2023.02.039","volume":"11","author":"Y Zhao","year":"2024","unstructured":"Zhao Y, Xing C, Deng Y, Ye C, Peng H. HIF-1\u03b1 signaling: essential roles in tumorigenesis and implications in targeted therapies. Genes Dis. 2024;11(1):234\u201351.","journal-title":"Genes Dis"},{"issue":"1Suppl 1","key":"6702_CR117","doi-asserted-by":"publisher","first-page":"S184","DOI":"10.1093\/carcin\/bgv036","volume":"36","author":"Z Hu","year":"2015","unstructured":"Hu Z, Brooks SA, Dormoy V, Hsu CW, Hsu HY, Lin LT, et al. Assessing the carcinogenic potential of low-dose exposures to chemical mixtures in the environment: focus on the cancer hallmark of tumor angiogenesis. Carcinogenesis. 2015;36(1Suppl 1):S184\u2013202.","journal-title":"Carcinogenesis"},{"issue":"1","key":"6702_CR118","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/s13046-020-01709-5","volume":"39","author":"X Jiang","year":"2020","unstructured":"Jiang X, Wang J, Deng X, Xiong F, Zhang S, Gong Z, et al. The role of microenvironment in tumor angiogenesis. J Exp Clin Cancer Res. 2020;39(1):204.","journal-title":"J Exp Clin Cancer Res"},{"key":"6702_CR119","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/s41392-020-00312-6","volume":"5","author":"H Yu","year":"2020","unstructured":"Yu H, Lin L, Zhang Z, Zhang H, Hu H. Targeting NF-\u03baB pathway for the therapy of diseases: mechanism and clinical study. Signal Transduct Target Ther. 2020;5:209.","journal-title":"Signal Transduct Target Ther"},{"key":"6702_CR120","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1146\/annurev.immunol.021908.132641","volume":"27","author":"S Vallabhapurapu","year":"2009","unstructured":"Vallabhapurapu S, Karin M. Regulation and function of NF-kappaB transcription factors in the immune system. Annu Rev Immunol. 2009;27:693\u2013733.","journal-title":"Annu Rev Immunol"},{"issue":"8","key":"6702_CR121","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1038\/ni.2065","volume":"12","author":"A Oeckinghaus","year":"2011","unstructured":"Oeckinghaus A, Hayden MS, Ghosh S. Crosstalk in NF-\u03baB signaling pathways. Nat Immunol. 2011;12(8):695\u2013708.","journal-title":"Nat Immunol"},{"key":"6702_CR122","doi-asserted-by":"crossref","unstructured":"Abramson J, Anderson G. Thymic Epithelial Cells. Annu Rev Immunol. 2017 Apr 26;35:85\u2013118.","DOI":"10.1146\/annurev-immunol-051116-052320"},{"issue":"2","key":"6702_CR123","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/s41573-022-00571-8","volume":"22","author":"O Hassin","year":"2023","unstructured":"Hassin O, Oren M. Drugging p53 in cancer: one protein, many targets. Nat Rev Drug Discov. 2023;22(2):127\u201344.","journal-title":"Nat Rev Drug Discov"},{"key":"6702_CR124","doi-asserted-by":"crossref","unstructured":"Lee JH, Sancar A. Regulation of apoptosis by the circadian clock through NF-\u03baB signaling. Proceedings of the National Academy of Sciences. 2011;108(29):12036\u201341.","DOI":"10.1073\/pnas.1108125108"},{"issue":"1","key":"6702_CR125","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.intimp.2015.07.001","volume":"28","author":"L Yang","year":"2015","unstructured":"Yang L, Chu Y, Wang L, Wang Y, Zhao X, He W, et al. Overexpression of CRY1 protects against the development of atherosclerosis via the TLR\/NF-\u03baB pathway. Int Immunopharmacol. 2015;28(1):525\u201330.","journal-title":"Int Immunopharmacol"},{"issue":"7","key":"6702_CR126","doi-asserted-by":"publisher","first-page":"415","DOI":"10.5483\/BMBRep.2019.52.7.152","volume":"52","author":"H Lee","year":"2019","unstructured":"Lee H, Jeong AJ, Ye SK. Highlighted STAT3 as a potential drug target for cancer therapy. BMB Rep. 2019;52(7):415\u201323.","journal-title":"BMB Rep"},{"key":"6702_CR127","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.pharmthera.2015.10.004","volume":"162","author":"EZP Chai","year":"2016","unstructured":"Chai EZP, Shanmugam MK, Arfuso F, Dharmarajan A, Wang C, Kumar AP, et al. Targeting transcription factor STAT3 for cancer prevention and therapy. Pharmacol Ther. 2016;162:86\u201397.","journal-title":"Pharmacol Ther"},{"issue":"1","key":"6702_CR128","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s13046-024-02949-5","volume":"43","author":"Y Hu","year":"2024","unstructured":"Hu Y, Dong Z, Liu K. Unraveling the complexity of STAT3 in cancer: molecular Understanding and drug discovery. J Experimental Clin Cancer Res. 2024;43(1):23.","journal-title":"J Experimental Clin Cancer Res"},{"issue":"2","key":"6702_CR129","first-page":"136","volume":"1845","author":"KS Siveen","year":"2014","unstructured":"Siveen KS, Sikka S, Surana R, Dai X, Zhang J, Kumar AP, et al. Targeting the STAT3 signaling pathway in cancer: role of synthetic and natural inhibitors. Biochimica et biophysica acta (BBA) -. Reviews Cancer. 2014;1845(2):136\u201354.","journal-title":"Reviews Cancer"},{"issue":"8","key":"6702_CR130","doi-asserted-by":"publisher","first-page":"6386","DOI":"10.18632\/oncotarget.3443","volume":"6","author":"JH Lee","year":"2015","unstructured":"Lee JH, Kim C, Sethi G, Ahn KS. Brassinin inhibits STAT3 signaling pathway through modulation of PIAS-3 and SOCS-3 expression and sensitizes human lung cancer xenograft in nude mice to Paclitaxel. Oncotarget. 2015;6(8):6386\u2013405.","journal-title":"Oncotarget"},{"issue":"3","key":"6702_CR131","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/s41568-022-00537-3","volume":"23","author":"YJ Li","year":"2023","unstructured":"Li YJ, Zhang C, Martincuks A, Herrmann A, Yu H. STAT proteins in cancer: orchestration of metabolism. Nat Rev Cancer. 2023;23(3):115\u201334.","journal-title":"Nat Rev Cancer"},{"key":"6702_CR132","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.freeradbiomed.2019.09.036","volume":"145","author":"G Ji","year":"2019","unstructured":"Ji G, Lv K, Chen H, Wang Y, Zhang Y, Li Y, et al. Hydrogen peroxide modulates clock gene expression via PRX2-STAT3-REV-ERB\u03b1\/\u03b2 pathway. Free Radic Biol Med. 2019;145:312\u201320.","journal-title":"Free Radic Biol Med"},{"issue":"6","key":"6702_CR133","doi-asserted-by":"publisher","first-page":"699","DOI":"10.21873\/cgp.20291","volume":"18","author":"GH HAN","year":"2021","unstructured":"HAN GH, KIM J, YUN H, CHO H, CHUNG JY, KIM JH, et al. CRY1 regulates chemoresistance in association with NANOG by inhibiting apoptosis via STAT3 pathway in patients with cervical Cancer. Cancer Genomics Proteom. 2021;18(6):699\u2013713.","journal-title":"Cancer Genomics Proteom"},{"issue":"2","key":"6702_CR134","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.ceb.2008.02.005","volume":"20","author":"DA Salih","year":"2008","unstructured":"Salih DA, Brunet A. FoxO transcription factors in the maintenance of cellular homeostasis during aging. Curr Opin Cell Biol. 2008;20(2):126\u201336.","journal-title":"Curr Opin Cell Biol"},{"key":"6702_CR135","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.semcancer.2018.01.004","volume":"50","author":"RK Yadav","year":"2018","unstructured":"Yadav RK, Chauhan AS, Zhuang L, Gan B. FoxO transcription factors in cancer metabolism. Semin Cancer Biol. 2018;50:65\u201376.","journal-title":"Semin Cancer Biol"},{"issue":"6","key":"6702_CR136","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1007\/s00018-015-2112-y","volume":"73","author":"A Coomans de Brach\u00e8ne","year":"2015","unstructured":"Coomans de Brach\u00e8ne A, Demoulin JB. FOXO transcription factors in cancer development and therapy. Cell Mol Life Sci. 2015;73(6):1159\u201372.","journal-title":"Cell Mol Life Sci"},{"issue":"16","key":"6702_CR137","doi-asserted-by":"publisher","first-page":"2312","DOI":"10.1038\/onc.2008.24","volume":"27","author":"Z Fu","year":"2008","unstructured":"Fu Z, Tindall D. FOXOs, cancer and regulation of apoptosis. Oncogene. 2008;27(16):2312.","journal-title":"Oncogene"},{"issue":"1","key":"6702_CR138","doi-asserted-by":"publisher","first-page":"70","DOI":"10.3390\/antiox14010070","volume":"14","author":"G Guan","year":"2025","unstructured":"Guan G, Chen Y, Dong Y. Unraveling the AMPK-SIRT1-FOXO pathway: the In-Depth analysis and breakthrough prospects of oxidative Stress-Induced diseases. Antioxid (Basel). 2025;14(1):70.","journal-title":"Antioxid (Basel)"},{"issue":"9","key":"6702_CR139","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1002\/art.41284","volume":"72","author":"T Duffy","year":"2020","unstructured":"Duffy T, Bekki H, Lotz MK. Genome-wide occupancy profiling reveals critical roles of FOXO1 in regulating extracellular matrix and circadian rhythm genes in human chondrocytes. Arthritis Rheumatol. 2020;72(9):1514\u201323.","journal-title":"Arthritis Rheumatol"},{"issue":"9","key":"6702_CR140","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.3390\/cells8091110","volume":"8","author":"C Fasano","year":"2019","unstructured":"Fasano C, Disciglio V, Bertora S, Lepore Signorile M, Simone C. FOXO3a from the nucleus to the mitochondria: A round trip in cellular stress response. Cells. 2019;8(9):1110.","journal-title":"Cells"},{"issue":"17","key":"6702_CR141","doi-asserted-by":"publisher","first-page":"13662","DOI":"10.3390\/ijms241713662","volume":"24","author":"S Draijer","year":"2023","unstructured":"Draijer S, Timmerman R, Pannekeet J, van Harten A, Farshadi EA, Kemmer J, et al. FoxO3 modulates circadian rhythms in neural stem cells. Int J Mol Sci. 2023;24(17):13662.","journal-title":"Int J Mol Sci"},{"issue":"7","key":"6702_CR142","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1038\/nrm3598","volume":"14","author":"J Briscoe","year":"2013","unstructured":"Briscoe J, Th\u00e9rond PP. The mechanisms of Hedgehog signalling and its roles in development and disease. Nat Rev Mol Cell Biol. 2013;14(7):416\u201329.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"11","key":"6702_CR143","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1186\/gb-2008-9-11-241","volume":"9","author":"TR B\u00fcrglin","year":"2008","unstructured":"B\u00fcrglin TR. The Hedgehog protein family. Genome Biol. 2008;9(11):241.","journal-title":"Genome Biol"},{"issue":"7716","key":"6702_CR144","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/s41586-018-0308-7","volume":"560","author":"X Qi","year":"2018","unstructured":"Qi X, Schmiege P, Coutavas E, Wang J, Li X. Structures of human patched and its complex with native palmitoylated Sonic Hedgehog. Nature. 2018;560(7716):128\u201332.","journal-title":"Nature"},{"issue":"2","key":"6702_CR145","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.devcel.2018.11.015","volume":"48","author":"WC Yin","year":"2019","unstructured":"Yin WC, Satkunendran T, Mo R, Morrissy S, Zhang X, Huang ES, et al. Dual regulatory functions of SUFU and targetome of GLI2 in SHH subgroup Medulloblastoma. Dev Cell. 2019;48(2):167\u2013e1835.","journal-title":"Dev Cell"},{"issue":"4","key":"6702_CR146","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.devcel.2016.07.026","volume":"38","author":"E Pak","year":"2016","unstructured":"Pak E, Segal RA. Hedgehog signal transduction: key players, oncogenic drivers, and Cancer therapy. Dev Cell. 2016;38(4):333\u201344.","journal-title":"Dev Cell"},{"issue":"1","key":"6702_CR147","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41392-023-01559-5","volume":"8","author":"J Jing","year":"2023","unstructured":"Jing J, Wu Z, Wang J, Luo G, Lin H, Fan Y, et al. Hedgehog signaling in tissue homeostasis, cancers and targeted therapies. Sig Transduct Target Ther. 2023;8(1):1\u201333.","journal-title":"Sig Transduct Target Ther"},{"issue":"8","key":"6702_CR148","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41419-023-06032-3","volume":"14","author":"J Yang","year":"2023","unstructured":"Yang J, Liu Y, Liu S. The role of epithelial-mesenchymal transition and autophagy in pancreatic ductal adenocarcinoma invasion. Cell Death Dis. 2023;14(8):1\u201314.","journal-title":"Cell Death Dis"},{"issue":"6648","key":"6702_CR149","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1126\/science.abm1962","volume":"380","author":"HQ Tu","year":"2023","unstructured":"Tu HQ, Li S, Xu YL, Zhang YC, Li PY, Liang LY, et al. Rhythmic cilia changes support SCN neuron coherence in circadian clock. Science. 2023;380(6648):972\u20139.","journal-title":"Science"},{"issue":"6","key":"6702_CR150","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1016\/j.jhep.2019.01.022","volume":"70","author":"E Marbach-Breitr\u00fcck","year":"2019","unstructured":"Marbach-Breitr\u00fcck E, Matz-Soja M, Abraham U, Schmidt-Heck W, Sales S, Rennert C, et al. Tick-tock hedgehog-mutual crosstalk with liver circadian clock promotes liver steatosis. J Hepatol. 2019;70(6):1192\u2013202.","journal-title":"J Hepatol"},{"issue":"43","key":"6702_CR151","doi-asserted-by":"publisher","first-page":"36081","DOI":"10.1074\/jbc.M112.408963","volume":"287","author":"T Takarada","year":"2012","unstructured":"Takarada T, Kodama A, Hotta S, Mieda M, Shimba S, Hinoi E, et al. Clock genes influence gene expression in growth plate and endochondral ossification in mice. J Biol Chem. 2012;287(43):36081\u201395.","journal-title":"J Biol Chem"},{"issue":"3","key":"6702_CR152","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.3892\/or.2020.7914","volume":"45","author":"M Jia","year":"2021","unstructured":"Jia M, Su B, Mo L, Qiu W, Ying J, Lin P, et al. Circadian clock protein CRY1 prevents paclitaxel\u2013induced senescence of bladder cancer cells by promoting p53 degradation. Oncol Rep. 2021;45(3):1033\u201343.","journal-title":"Oncol Rep"},{"issue":"10","key":"6702_CR153","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1038\/s12276-021-00681-0","volume":"53","author":"Y Lee","year":"2021","unstructured":"Lee Y. Roles of circadian clocks in cancer pathogenesis and treatment. Exp Mol Med. 2021;53(10):1529\u201338.","journal-title":"Exp Mol Med"},{"issue":"3","key":"6702_CR154","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.cels.2018.01.013","volume":"6","author":"Y Ye","year":"2018","unstructured":"Ye Y, Xiang Y, Ozguc FM, Kim Y, Liu CJ, Park PK, et al. The genomic landscape and Pharmacogenomic interactions of clock genes in Cancer chronotherapy. Cell Syst. 2018;6(3):314\u2013e3282.","journal-title":"Cell Syst"},{"issue":"15","key":"6702_CR155","doi-asserted-by":"publisher","first-page":"2568","DOI":"10.1002\/cncr.35444","volume":"130","author":"MB Nierengarten","year":"2024","unstructured":"Nierengarten MB. Global cancer statistics 2022. Cancer. 2024;130(15):2568\u20132568.","journal-title":"Cancer"},{"key":"6702_CR156","doi-asserted-by":"publisher","first-page":"106917","DOI":"10.1016\/j.bspc.2024.106917","volume":"100","author":"BS Deo","year":"2025","unstructured":"Deo BS, Nayak S, Pal M, Panigrahi PK, Pradhan A. Empirical mode decomposition and Hessian LLE in fluorescence spectral signal analysis for cervical cancer detection. Biomed Signal Process Control. 2025;100:106917.","journal-title":"Biomed Signal Process Control"},{"key":"6702_CR157","doi-asserted-by":"crossref","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians. 2021;71(3):209\u201349.","DOI":"10.3322\/caac.21660"},{"issue":"9","key":"6702_CR158","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1002\/gcc.20577","volume":"47","author":"L Scotto","year":"2008","unstructured":"Scotto L, Narayan G, Nandula SV, Arias-Pulido H, Subramaniyam S, Schneider A, et al. Identification of copy number gain and overexpressed genes on chromosome arm 20q by an integrative genomic approach in cervical cancer: potential role in progression. Genes Chromosomes Cancer. 2008;47(9):755\u201365.","journal-title":"Genes Chromosomes Cancer"},{"issue":"21","key":"6702_CR159","doi-asserted-by":"publisher","first-page":"10163","DOI":"10.1158\/0008-5472.CAN-07-2056","volume":"67","author":"Y Zhai","year":"2007","unstructured":"Zhai Y, Kuick R, Nan B, Ota I, Weiss SJ, Trimble CL, et al. Gene expression analysis of preinvasive and invasive cervical squamous cell carcinomas identifies HOXC10 as a key mediator of invasion. Cancer Res. 2007;67(21):10163\u201372.","journal-title":"Cancer Res"},{"issue":"9","key":"6702_CR160","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1158\/1541-7786.MCR-19-1074","volume":"18","author":"PJ van der Watt","year":"2020","unstructured":"van der Watt PJ, Roden LC, Davis KT, Parker MI, Leaner VD. Circadian oscillations persist in cervical and esophageal Cancer cells displaying decreased expression of Tumor-Suppressing circadian clock genes. Mol Cancer Res. 2020;18(9):1340\u201353.","journal-title":"Mol Cancer Res"},{"issue":"3","key":"6702_CR161","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1001\/jama.2018.19323","volume":"321","author":"AG Waks","year":"2019","unstructured":"Waks AG, Winer EP. Breast Cancer treatment: A review. JAMA. 2019;321(3):288\u2013300.","journal-title":"JAMA"},{"issue":"10","key":"6702_CR162","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1002\/cac2.12358","volume":"42","author":"R Hong","year":"2022","unstructured":"Hong R, Xu B. Breast cancer: an up-to-date review and future perspectives. Cancer Commun. 2022;42(10):913\u201336.","journal-title":"Cancer Commun"},{"key":"6702_CR163","doi-asserted-by":"crossref","unstructured":"Dai H, Zhang L, Cao M, Song F, Zheng H, Zhu X, et al. The role of polymorphisms in circadian pathway genes in breast tumorigenesis. Breast Cancer Res Treat. 2011 Jun;127(2):531\u201340.","DOI":"10.1007\/s10549-010-1231-2"},{"issue":"5","key":"6702_CR164","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.canep.2013.04.006","volume":"37","author":"A Grundy","year":"2013","unstructured":"Grundy A, Schuetz JM, Lai AS, Janoo-Gilani R, Leach S, Burstyn I, et al. Shift work, circadian gene variants and risk of breast cancer. Cancer Epidemiol. 2013;37(5):606\u201312.","journal-title":"Cancer Epidemiol"},{"issue":"12","key":"6702_CR165","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1038\/s41423-018-0007-1","volume":"15","author":"L Hong","year":"2018","unstructured":"Hong L, Li X, Zhou D, Geng J, Chen L. Role of Hippo signaling in regulating immunity. Cell Mol Immunol. 2018;15(12):1003\u20139.","journal-title":"Cell Mol Immunol"},{"issue":"6","key":"6702_CR166","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.3390\/cells10061416","volume":"10","author":"Q Liu","year":"2021","unstructured":"Liu Q, Liu X, Song G. The Hippo pathway: A master regulatory network important in Cancer. Cells. 2021;10(6):1416.","journal-title":"Cells"},{"issue":"8","key":"6702_CR167","doi-asserted-by":"publisher","first-page":"107449","DOI":"10.1016\/j.isci.2023.107449","volume":"26","author":"A Azzi","year":"2023","unstructured":"Azzi A, Tao Z, Sun Y, Erb H, Guarino C, Wu X. The circadian clock protein Cryptochrome 1 is a direct target and feedback regulator of the Hippo pathway. iScience. 2023;26(8):107449.","journal-title":"iScience"},{"issue":"5","key":"6702_CR168","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/s41571-024-00881-3","volume":"21","author":"PM Webb","year":"2024","unstructured":"Webb PM, Jordan SJ. Global epidemiology of epithelial ovarian cancer. Nat Rev Clin Oncol. 2024;21(5):389\u2013400.","journal-title":"Nat Rev Clin Oncol"},{"issue":"10","key":"6702_CR169","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1080\/00016340802348286","volume":"87","author":"H Tokunaga","year":"2008","unstructured":"Tokunaga H, Takebayashi Y, Utsunomiya H, Akahira JI, Higashimoto M, Mashiko M, et al. Clinicopathological significance of circadian rhythm-related gene expression levels in patients with epithelial ovarian cancer. Acta Obstet Gynecol Scand. 2008;87(10):1060\u201370.","journal-title":"Acta Obstet Gynecol Scand"},{"key":"6702_CR170","doi-asserted-by":"crossref","unstructured":"Angelousi A, Kassi E, Ansari-Nasiri N, Randeva H, Kaltsas G, Chrousos G. Clock genes and cancer development in particular in endocrine tissues. Endocr Relat Cancer. 2019 Jun;26(6):R305\u201317.","DOI":"10.1530\/ERC-19-0094"},{"issue":"4","key":"6702_CR171","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/s11523-023-00970-w","volume":"18","author":"DM O\u2019Malley","year":"2023","unstructured":"O\u2019Malley DM, Krivak TC, Kabil N, Munley J, Moore KN. PARP inhibitors in ovarian cancer: A review. Targ Oncol. 2023;18(4):471\u2013503.","journal-title":"Targ Oncol"},{"key":"6702_CR172","doi-asserted-by":"crossref","unstructured":"Iida Y, Yanaihara N, Yoshino Y, Saito M, Saito R, Tabata J, et al. Bevacizumab increases the sensitivity of olaparib to homologous recombination-proficient ovarian cancer by suppressing CRY1 via PI3K\/AKT pathway. Front Oncol. 2024;14:1302850.","DOI":"10.3389\/fonc.2024.1302850"},{"key":"6702_CR173","doi-asserted-by":"crossref","unstructured":"Smyth EC, Nilsson M, Grabsch HI, van Grieken NC, Lordick F. Gastric cancer. Lancet. 2020 Aug 29;396(10251):635\u201348.","DOI":"10.1016\/S0140-6736(20)31288-5"},{"key":"6702_CR174","doi-asserted-by":"crossref","unstructured":"Sung H, Siegel RL, Rosenberg PS, Jemal A. Emerging cancer trends among young adults in the USA: analysis of a population-based cancer registry. Lancet Public Health. 2019 Mar;4(3):e137\u201347.","DOI":"10.1016\/S2468-2667(18)30267-6"},{"issue":"11","key":"6702_CR175","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1016\/j.ejca.2012.01.009","volume":"48","author":"JL Dikken","year":"2012","unstructured":"Dikken JL, Lemmens VE, Wouters MWJM, Wijnhoven BP, Siersema PD, Nieuwenhuijzen GA, et al. Increased incidence and survival for oesophageal cancer but not for gastric cardia cancer in the Netherlands. Eur J Cancer. 2012;48(11):1624\u201332.","journal-title":"Eur J Cancer"},{"key":"6702_CR176","doi-asserted-by":"crossref","unstructured":"Howson CP, Hiyama T, Wynder EL. The decline in gastric cancer: epidemiology of an unplanned triumph. Epidemiol Rev. 1986;8:1\u201327.","DOI":"10.1093\/oxfordjournals.epirev.a036288"},{"issue":"11","key":"6702_CR177","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1038\/s41575-018-0069-7","volume":"15","author":"J O\u2019Sullivan","year":"2018","unstructured":"O\u2019Sullivan J, Lysaght J, Donohoe CL, Reynolds JV. Obesity and Gastrointestinal cancer: the interrelationship of adipose and tumour microenvironments. Nat Rev Gastroenterol Hepatol. 2018;15(11):699\u2013714.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"9","key":"6702_CR178","doi-asserted-by":"publisher","first-page":"e0138580","DOI":"10.1371\/journal.pone.0138580","volume":"10","author":"J Han","year":"2015","unstructured":"Han J, Jiang Y, Liu X, Meng Q, Xi Q, Zhuang Q, et al. Dietary fat intake and risk of gastric cancer: A Meta-Analysis of observational studies. PLoS ONE. 2015;10(9):e0138580.","journal-title":"PLoS ONE"},{"key":"6702_CR179","doi-asserted-by":"crossref","unstructured":"Shay JES, Yilmaz \u00d6H. Dietary and metabolic effects on intestinal stem cells in health and disease. Nat Rev Gastroenterol Hepatol. 2024;1\u201316.","DOI":"10.1038\/s41575-024-00980-7"},{"issue":"1","key":"6702_CR180","first-page":"808120","volume":"2012","author":"S Ge","year":"2012","unstructured":"Ge S, Feng X, Shen L, Wei Z, Zhu Q, Sun J. Association between habitual dietary salt intake and risk of gastric cancer: A systematic review of observational studies. Gastroenterol Res Pract. 2012;2012(1):808120.","journal-title":"Gastroenterol Res Pract"},{"issue":"4","key":"6702_CR181","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.clnu.2012.01.003","volume":"31","author":"L D\u2019Elia","year":"2012","unstructured":"D\u2019Elia L, Rossi G, Ippolito R, Cappuccio FP, Strazzullo P. Habitual salt intake and risk of gastric cancer: a meta-analysis of prospective studies. Clin Nutr. 2012;31(4):489\u201398.","journal-title":"Clin Nutr"},{"issue":"6","key":"6702_CR182","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1002\/ijc.28777","volume":"135","author":"P Li","year":"2014","unstructured":"Li P, Zhang H, Chen J, Shi Y, Cai J, Yang J, et al. Association between dietary antioxidant vitamins intake\/blood level and risk of gastric cancer. Int J Cancer. 2014;135(6):1444\u201353.","journal-title":"Int J Cancer"},{"issue":"6","key":"6702_CR183","doi-asserted-by":"publisher","first-page":"E963","DOI":"10.1002\/ijc.27517","volume":"131","author":"SM Jeurnink","year":"2012","unstructured":"Jeurnink SM, B\u00fcchner FL, Bueno-de-Mesquita HB, Siersema PD, Boshuizen HC, Numans ME, et al. Variety in vegetable and fruit consumption and the risk of gastric and esophageal cancer in the European prospective investigation into Cancer and nutrition. Int J Cancer. 2012;131(6):E963\u2013973.","journal-title":"Int J Cancer"},{"issue":"5","key":"6702_CR184","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1007\/s10552-007-9107-4","volume":"19","author":"ND Freedman","year":"2008","unstructured":"Freedman ND, Subar AF, Hollenbeck AR, Leitzmann MF, Schatzkin A, Abnet CC. Fruit and vegetable intake and gastric cancer risk in a large united States prospective cohort study. Cancer Causes Control. 2008;19(5):459\u201367.","journal-title":"Cancer Causes Control"},{"issue":"4","key":"6702_CR185","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/s41580-018-0096-9","volume":"20","author":"H Reinke","year":"2019","unstructured":"Reinke H, Asher G. Crosstalk between metabolism and circadian clocks. Nat Rev Mol Cell Biol. 2019;20(4):227\u201341.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"7","key":"6702_CR186","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1038\/hr.2016.12","volume":"39","author":"I Shimizu","year":"2016","unstructured":"Shimizu I, Yoshida Y, Minamino T. A role for circadian clock in metabolic disease. Hypertens Res. 2016;39(7):483\u201391.","journal-title":"Hypertens Res"},{"issue":"2","key":"6702_CR187","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1111\/febs.15360","volume":"288","author":"S Cal-Kayitmazbatir","year":"2021","unstructured":"Cal-Kayitmazbatir S, Kulkoyluoglu-Cotul E, Growe J, Selby CP, Rhoades SD, Malik D, et al. CRY1-CBS binding regulates circadian clock function and metabolism. FEBS J. 2021;288(2):614.","journal-title":"FEBS J"},{"issue":"1","key":"6702_CR188","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/1471-230X-14-67","volume":"14","author":"ML Hu","year":"2014","unstructured":"Hu ML, Yeh KT, Lin PM, Hsu CM, Hsiao HH, Liu YC, et al. Deregulated expression of circadian clock genes in gastric cancer. BMC Gastroenterol. 2014;14(1):67.","journal-title":"BMC Gastroenterol"},{"key":"6702_CR189","doi-asserted-by":"crossref","unstructured":"Shen K, Liu T. Comprehensive Analysis of the Prognostic Value and Immune Function of Immune Checkpoints in Stomach Adenocarcinoma. Int J Gen Med. 2021;14:5807\u201324.","DOI":"10.2147\/IJGM.S325467"},{"key":"6702_CR190","doi-asserted-by":"crossref","unstructured":"Xue W, Dong B, Wang Y, Xie Y, Li P, Gong Z, et al. A novel prognostic index of stomach adenocarcinoma based on immunogenomic landscape analysis and immunotherapy options. Experimental and Molecular Pathology. 2022 Oct 1;128:104832.","DOI":"10.1016\/j.yexmp.2022.104832"},{"issue":"12","key":"6702_CR191","doi-asserted-by":"publisher","first-page":"16637","DOI":"10.18632\/aging.203184","volume":"13","author":"Z Huang","year":"2021","unstructured":"Huang Z, He A, Wang J, Lu H, Zhang R, Wu L, et al. The circadian clock is associated with prognosis and immune infiltration in stomach adenocarcinoma. Aging. 2021;13(12):16637\u201355.","journal-title":"Aging"},{"issue":"11","key":"6702_CR192","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1056\/NEJMoa2304714","volume":"390","author":"DC Chung","year":"2024","unstructured":"Chung DC, Gray DM, Singh H, Issaka RB, Raymond VM, Eagle C, et al. A Cell-free DNA Blood-Based test for colorectal Cancer screening. N Engl J Med. 2024;390(11):973\u201383.","journal-title":"N Engl J Med"},{"key":"6702_CR193","doi-asserted-by":"crossref","unstructured":"Sl\u00e1dek M, Rybov\u00e1 M, Jindr\u00e1kov\u00e1 Z, Zemanov\u00e1 Z, Polidarov\u00e1 L, Mrnka L, et al. Insight into the circadian clock within rat colonic epithelial cells. Gastroenterology. 2007 Oct;133(4):1240\u20139.","DOI":"10.1053\/j.gastro.2007.05.053"},{"key":"6702_CR194","doi-asserted-by":"crossref","unstructured":"L\u00e9vi F, Dugu\u00e9 PA, Innominato P, Karabou\u00e9 A, Dispersyn G, Parganiha A, et al. Wrist actimetry circadian rhythm as a robust predictor of colorectal cancer patients survival. Chronobiol Int. 2014 Oct;31(8):891\u2013900.","DOI":"10.3109\/07420528.2014.924523"},{"key":"6702_CR195","doi-asserted-by":"crossref","unstructured":"Hu L, Li G, Shu Y, Hou X, Yang L, Jin Y. Circadian dysregulation induces alterations of visceral sensitivity and the gut microbiota in Light\/Dark phase shift mice. Front Microbiol. 2022;13:935919.","DOI":"10.3389\/fmicb.2022.935919"},{"issue":"10","key":"6702_CR196","doi-asserted-by":"publisher","first-page":"841","DOI":"10.3109\/07420528.2011.615182","volume":"28","author":"G Mazzoccoli","year":"2011","unstructured":"Mazzoccoli G, Panza A, Valvano MR, Palumbo O, Carella M, Pazienza V, et al. Clock gene expression levels and relationship with clinical and pathological features in colorectal cancer patients. Chronobiol Int. 2011;28(10):841\u201351.","journal-title":"Chronobiol Int"},{"issue":"4","key":"6702_CR197","doi-asserted-by":"publisher","first-page":"e61679","DOI":"10.1371\/journal.pone.0061679","volume":"8","author":"H Yu","year":"2013","unstructured":"Yu H, Meng X, Wu J, Pan C, Ying X, Zhou Y, et al. Cryptochrome 1 overexpression correlates with tumor progression and poor prognosis in patients with colorectal Cancer. PLoS ONE. 2013;8(4):e61679.","journal-title":"PLoS ONE"},{"key":"6702_CR198","doi-asserted-by":"crossref","unstructured":"Mazzoccoli G, Colangelo T, Panza A, Rubino R, De Cata A, Tiberio C, et al. Deregulated expression of cryptochrome genes in human colorectal cancer. Mol Cancer. 2016 Jan 15;15:6.","DOI":"10.1186\/s12943-016-0492-8"},{"issue":"6","key":"6702_CR199","doi-asserted-by":"publisher","first-page":"986","DOI":"10.4149\/neo_2018_180122N47","volume":"65","author":"K Hasakova","year":"2018","unstructured":"Hasakova K, Vician M, Reis R, Zeman M, Herichova I. The expression of clock genes cry1 and cry2 in human colorectal cancer and tumor adjacent tissues correlates differently dependent on tumor location. Neoplasma. 2018;65(6):986\u201392.","journal-title":"Neoplasma"},{"issue":"10","key":"6702_CR200","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1080\/07420528.2018.1488722","volume":"35","author":"K Hasakova","year":"2018","unstructured":"Hasakova K, Vician M, Reis R, Zeman M, Herichova I. Sex-dependent correlation between survival and expression of genes related to the circadian oscillator in patients with colorectal cancer. Chronobiol Int. 2018;35(10):1423\u201334.","journal-title":"Chronobiol Int"},{"key":"6702_CR201","doi-asserted-by":"crossref","unstructured":"Aroca-Siendones MI, Moreno-SanJuan S, Puentes-Pardo JD, Verbeni M, Arnedo J, Escudero-Feliu J, et al. Core Circadian Clock Proteins as Biomarkers of Progression in Colorectal Cancer. Biomedicines. 2021 Aug 6;9(8):967.","DOI":"10.3390\/biomedicines9080967"},{"key":"6702_CR202","doi-asserted-by":"crossref","unstructured":"Rao X, Lin L. Circadian clock as a possible control point in colorectal cancer progression (Review). Int J Oncol. 2022 Dec;61(6):149.","DOI":"10.3892\/ijo.2022.5439"},{"issue":"2","key":"6702_CR203","doi-asserted-by":"publisher","first-page":"424","DOI":"10.3390\/biomedicines12020424","volume":"12","author":"P \u0160tef\u00e1nik","year":"2024","unstructured":"\u0160tef\u00e1nik P, Morov\u00e1 M, Herichov\u00e1 I. Impact of Long-Lasting environmental factors on regulation mediated by the miR-34 family. Biomedicines. 2024;12(2):424.","journal-title":"Biomedicines"},{"issue":"17","key":"6702_CR204","doi-asserted-by":"publisher","first-page":"5730","DOI":"10.3390\/molecules27175730","volume":"27","author":"M Sekhoacha","year":"2022","unstructured":"Sekhoacha M, Riet K, Motloung P, Gumenku L, Adegoke A, Mashele S. Prostate Cancer review: genetics, diagnosis, treatment options, and alternative approaches. Molecules. 2022;27(17):5730.","journal-title":"Molecules"},{"key":"6702_CR205","doi-asserted-by":"crossref","unstructured":"Kattan MW, Eastham JA, Stapleton AMF, Wheeler TM, Scardino PT. A Preoperative Nomogram for Disease Recurrence Following Radical Prostatectomy for Prostate Cancer. JNCI: Journal of the National Cancer Institute. 1998 May 20;90(10):766\u201371.","DOI":"10.1093\/jnci\/90.10.766"},{"issue":"9","key":"6702_CR206","doi-asserted-by":"publisher","first-page":"1928","DOI":"10.1158\/1055-9965.EPI-11-0236","volume":"20","author":"DW Lin","year":"2011","unstructured":"Lin DW, FitzGerald LM, Fu R, Kwon EM, Zheng SL, Kolb S, et al. Genetic variants in the LEPR, CRY1, RNASEL, IL4, and ARVCF genes are prognostic markers of prostate cancer-specific mortality. Cancer Epidemiol Biomarkers Prev. 2011;20(9):1928\u201336.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"1","key":"6702_CR207","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s10552-014-0478-z","volume":"26","author":"SC Markt","year":"2015","unstructured":"Markt SC, Valdimarsdottir UA, Shui IM, Sigurdardottir LG, Rider JR, Tamimi RM, et al. Circadian clock genes and risk of fatal prostate cancer. Cancer Causes Control. 2015;26(1):25\u201333.","journal-title":"Cancer Causes Control"},{"key":"6702_CR208","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.semcancer.2023.03.003","volume":"91","author":"C Miro","year":"2023","unstructured":"Miro C, Docimo A, Barrea L, Verde L, Cernea S, Sojat AS, et al. Time for obesity-related cancer: the role of the circadian rhythm in cancer pathogenesis and treatment. Sem Cancer Biol. 2023;91:99\u2013109.","journal-title":"Sem Cancer Biol"},{"key":"6702_CR209","first-page":"2817","volume":"8","author":"D Rao","year":"2015","unstructured":"Rao D, Yu H, Bai Y, Zheng X, Xie L. Does night-shift work increase the risk of prostate cancer? A systematic review and meta-analysis. OTT. 2015;8:2817\u201326.","journal-title":"OTT"},{"issue":"4","key":"6702_CR210","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1007\/s10552-005-9010-9","volume":"17","author":"S Davis","year":"2006","unstructured":"Davis S, Mirick DK, Circadian, Disruption. Shift work and the risk of cancer: A summary of the evidence and studies in Seattle. Cancer Causes Control. 2006;17(4):539\u201345.","journal-title":"Cancer Causes Control"},{"issue":"5","key":"6702_CR211","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1002\/ijc.29400","volume":"137","author":"K Papantoniou","year":"2015","unstructured":"Papantoniou K, Casta\u00f1o-Vinyals G, Espinosa A, Aragon\u00e9s N, P\u00e9rez-G\u00f3mez B, Burgos J, et al. Night shift work, chronotype and prostate cancer risk in the MCC-Spain case-control study. Int J Cancer. 2015;137(5):1147\u201357.","journal-title":"Int J Cancer"},{"issue":"10","key":"6702_CR212","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1093\/aje\/kwz167","volume":"188","author":"C Barul","year":"2019","unstructured":"Barul C, Richard H, Parent ME. Night-Shift work and risk of prostate cancer: results from a Canadian Case-Control study, the prostate Cancer and environment study. Am J Epidemiol. 2019;188(10):1801\u201311.","journal-title":"Am J Epidemiol"},{"key":"6702_CR213","unstructured":"Mucciolo G, Henriquez JA, Jihad M, Teles SP, Manansala JS, Li W et al. EGFR-activated myofibroblasts promote metastasis of pancreatic cancer. Cancer Cell [Internet]. 2024 Jan 8 [cited 2024 Oct 9];42(1). Available from: https:\/\/webofscience.clarivate.cn\/api\/gateway?GWVersion=2&SrcAuth=DOISource&SrcApp=UA&KeyAID=10.1016%2Fj.ccell.2023.12.002&DestApp=DOI&SrcAppSID=USW2EC0D5D2yqX9A1n90pWzxEWYv0&SrcJTitle=CANCER+CELL&DestDOIRegistrantName=Elsevier"},{"key":"6702_CR214","doi-asserted-by":"publisher","first-page":"1347683","DOI":"10.3389\/fimmu.2024.1347683","volume":"15","author":"H Yang","year":"2024","unstructured":"Yang H, Li Z, Zhu S, Wang W, Zhang J, Zhao D, et al. Molecular mechanisms of pancreatic cancer liver metastasis: the role of PAK2. Front Immunol. 2024;15:1347683.","journal-title":"Front Immunol"},{"issue":"9","key":"6702_CR215","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1093\/jnci\/94.9.690","volume":"94","author":"E Filipski","year":"2002","unstructured":"Filipski E, King VM, Li X, Granda TG, Mormont MC, Liu X, et al. Host circadian clock as a control point in tumor progression. J Natl Cancer Inst. 2002;94(9):690\u20137.","journal-title":"J Natl Cancer Inst"},{"key":"6702_CR216","doi-asserted-by":"crossref","unstructured":"Fu L, Kettner NM. The circadian clock in cancer development and therapy. Prog Mol Biol Transl Sci. 2013;119:221\u201382.","DOI":"10.1016\/B978-0-12-396971-2.00009-9"},{"key":"6702_CR217","doi-asserted-by":"crossref","unstructured":"Sarantis P, Koustas E, Papadimitropoulou A, Papavassiliou AG, Karamouzis MV. Pancreatic ductal adenocarcinoma: Treatment hurdles, tumor microenvironment and immunotherapy. World J Gastrointest Oncol. 2020 Feb 15;12(2):173\u201381.","DOI":"10.4251\/wjgo.v12.i2.173"},{"issue":"3","key":"6702_CR218","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1038\/s43018-022-00349-2","volume":"3","author":"AN Hosein","year":"2022","unstructured":"Hosein AN, Dougan SK, Aguirre AJ, Maitra A. Translational advances in pancreatic ductal adenocarcinoma therapy. Nat Cancer. 2022;3(3):272\u201386.","journal-title":"Nat Cancer"},{"key":"6702_CR219","doi-asserted-by":"crossref","unstructured":"Relles D, Sendecki J, Chipitsyna G, Hyslop T, Yeo CJ, Arafat HA. Circadian gene expression and clinicopathologic correlates in pancreatic cancer. J Gastrointest Surg. 2013 Mar;17(3):443\u201350.","DOI":"10.1007\/s11605-012-2112-2"},{"issue":"4","key":"6702_CR220","doi-asserted-by":"publisher","first-page":"497","DOI":"10.3109\/07420528.2014.1003351","volume":"32","author":"F Tavano","year":"2015","unstructured":"Tavano F, Pazienza V, Fontana A, Burbaci FP, Panebianco C, Saracino C, et al. SIRT1 and circadian gene expression in pancreatic ductal adenocarcinoma: effect of starvation. Chronobiol Int. 2015;32(4):497\u2013512.","journal-title":"Chronobiol Int"},{"issue":"1","key":"6702_CR221","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41572-023-00486-7","volume":"10","author":"M Weller","year":"2024","unstructured":"Weller M, Wen PY, Chang SM, Dirven L, Lim M, Monje M, et al. Glioma Nat Rev Dis Primers. 2024;10(1):1\u201323.","journal-title":"Glioma Nat Rev Dis Primers"},{"key":"6702_CR222","doi-asserted-by":"crossref","unstructured":"Byun YH, Park CK. Classification and Diagnosis of Adult Glioma: A Scoping Review. Brain Neurorehabil. 2022 Nov;15(3):e23.","DOI":"10.12786\/bn.2022.15.e23"},{"issue":"3","key":"6702_CR223","doi-asserted-by":"publisher","first-page":"e23","DOI":"10.12786\/bn.2022.15.e23","volume":"15","author":"YH Byun","year":"2022","unstructured":"Byun YH, Park CK. Classification and diagnosis of adult glioma: A scoping review. Brain Neurorehabil. 2022;15(3):e23.","journal-title":"Brain Neurorehabil"},{"issue":"11","key":"6702_CR224","doi-asserted-by":"publisher","first-page":"5725","DOI":"10.7314\/APJCP.2012.13.11.5725","volume":"13","author":"Y Luo","year":"2012","unstructured":"Luo Y, Wang F, Chen LA, Chen XW, Chen ZJ, Liu PF, et al. Deregulated expression of cry1 and cry2 in human gliomas. Asian Pac J Cancer Prev. 2012;13(11):5725\u20138.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"1","key":"6702_CR225","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s10552-013-0305-y","volume":"25","author":"MH Madden","year":"2014","unstructured":"Madden MH, Anic GM, Thompson RC, Nabors LB, Olson JJ, Browning JE, et al. Circadian pathway genes in relation to glioma risk and outcome. Cancer Causes Control. 2014;25(1):25\u201332.","journal-title":"Cancer Causes Control"},{"issue":"3","key":"6702_CR226","doi-asserted-by":"publisher","first-page":"e12988","DOI":"10.1111\/cpr.12988","volume":"54","author":"Z Wang","year":"2021","unstructured":"Wang Z, Su G, Dai Z, Meng M, Zhang H, Fan F, et al. Circadian clock genes promote glioma progression by affecting tumour immune infiltration and tumour cell proliferation. Cell Prolif. 2021;54(3):e12988.","journal-title":"Cell Prolif"},{"issue":"1","key":"6702_CR227","doi-asserted-by":"publisher","first-page":"4632","DOI":"10.1038\/ncomms5632","volume":"5","author":"D Annibali","year":"2014","unstructured":"Annibali D, Whitfield JR, Favuzzi E, Jauset T, Serrano E, Cuartas I, et al. Myc Inhibition is effective against glioma and reveals a role for Myc in proficient mitosis. Nat Commun. 2014;5(1):4632.","journal-title":"Nat Commun"},{"key":"6702_CR228","doi-asserted-by":"crossref","unstructured":"Kozono D, Li J, Nitta M, Sampetrean O, Gonda D, Kushwaha DS et al. Dynamic epigenetic regulation of glioblastoma tumorigenicity through LSD1 modulation of MYC expression. Proceedings of the National Academy of Sciences. 2015;112(30):E4055\u201364.","DOI":"10.1073\/pnas.1501967112"},{"issue":"1","key":"6702_CR229","doi-asserted-by":"publisher","first-page":"27569","DOI":"10.1038\/srep27569","volume":"6","author":"Y Oktay","year":"2016","unstructured":"Oktay Y, \u00dclgen E, Can \u00d6, Akyerli CB, Y\u00fcksel \u015e, Erdemgil Y, et al. IDH-mutant glioma specific association of rs55705857 located at 8q24.21 involves MYC deregulation. Sci Rep. 2016;6(1):27569.","journal-title":"Sci Rep"},{"issue":"4","key":"6702_CR230","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.3390\/ijms23042043","volume":"23","author":"P Jarabo","year":"2022","unstructured":"Jarabo P, de Pablo C, Gonz\u00e1lez-Blanco A, Casas-Tint\u00f3 S. Circadian gene cry controls tumorigenesis through modulation of Myc accumulation in glioblastoma cells. Int J Mol Sci. 2022;23(4):2043.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"6702_CR231","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41698-024-00530-z","volume":"8","author":"N Nelson","year":"2024","unstructured":"Nelson N, Rel\u00f3gio A. Molecular mechanisms of tumour development in glioblastoma: an emerging role for the circadian clock. Npj Precis Onc. 2024;8(1):1\u201318.","journal-title":"Npj Precis Onc"},{"issue":"6","key":"6702_CR232","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/j.bbabio.2010.08.010","volume":"1807","author":"R Diaz-Ruiz","year":"2011","unstructured":"Diaz-Ruiz R, Rigoulet M, Devin A. The Warburg and Crabtree effects: on the origin of cancer cell energy metabolism and of yeast glucose repression. Biochim Et Biophys Acta (BBA) - Bioenergetics. 2011;1807(6):568\u201376.","journal-title":"Biochim Et Biophys Acta (BBA) - Bioenergetics"},{"issue":"3","key":"6702_CR233","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.bpg.2010.04.005","volume":"24","author":"M Risio","year":"2010","unstructured":"Risio M. The natural history of adenomas. Best Pract Res Clin Gastroenterol. 2010;24(3):271\u201380.","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"7","key":"6702_CR234","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/nrendo.2014.64","volume":"10","author":"A Di Ieva","year":"2014","unstructured":"Di Ieva A, Rotondo F, Syro LV, Cusimano MD, Kovacs K. Aggressive pituitary adenomas\u2014diagnosis and emerging treatments. Nat Rev Endocrinol. 2014;10(7):423\u201335.","journal-title":"Nat Rev Endocrinol"},{"issue":"5","key":"6702_CR235","doi-asserted-by":"publisher","first-page":"494","DOI":"10.3390\/biomedicines9050494","volume":"9","author":"S Banskota","year":"2021","unstructured":"Banskota S, Adamson DC. Pituitary adenomas: from diagnosis to therapeutics. Biomedicines. 2021;9(5):494.","journal-title":"Biomedicines"},{"issue":"2","key":"6702_CR236","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1016\/j.mce.2013.11.004","volume":"382","author":"D Becquet","year":"2014","unstructured":"Becquet D, Boyer B, Rasolonjanahary R, Brue T, Guillen S, Moreno M, et al. Evidence for an internal and functional circadian clock in rat pituitary cells. Mol Cell Endocrinol. 2014;382(2):888\u201398.","journal-title":"Mol Cell Endocrinol"},{"issue":"6","key":"6702_CR237","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.3390\/ijms19061675","volume":"19","author":"M Tetti","year":"2018","unstructured":"Tetti M, Castellano I, Venziano F, Magnino C, Veglio F, Mulatero P, et al. Role of Cryptochrome-1 and Cryptochrome-2 in Aldosterone-Producing adenomas and adrenocortical cells. Int J Mol Sci. 2018;19(6):1675.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"6702_CR238","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1007\/s12020-020-02246-z","volume":"68","author":"A Angelousi","year":"2020","unstructured":"Angelousi A, Nasiri-Ansari N, Karapanagioti A, Kyriakopoulos G, Aggeli C, Zografos G, et al. Expression of clock-related genes in benign and malignant adrenal tumors. Endocrine. 2020;68(3):650\u20139.","journal-title":"Endocrine"},{"issue":"1","key":"6702_CR239","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.bpg.2004.11.005","volume":"19","author":"C Cha","year":"2005","unstructured":"Cha C, DeMatteo RP. Molecular mechanisms in hepatocellular carcinoma development. Best Pract Res Clin Gastroenterol. 2005;19(1):25\u201337.","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"2","key":"6702_CR240","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1080\/07420528.2016.1256300","volume":"34","author":"H Li","year":"2017","unstructured":"Li H, Lu YF, Chen H, Liu J. Dysregulation of Metallothionein and circadian genes in human hepatocellular carcinoma. Chronobiol Int. 2017;34(2):192\u2013202.","journal-title":"Chronobiol Int"},{"issue":"3","key":"6702_CR241","doi-asserted-by":"publisher","first-page":"108","DOI":"10.14744\/hf.2023.2023.0009","volume":"4","author":"D Ayan","year":"2023","unstructured":"Ayan D, Cagatay A. Bioinformatic analysis of genetic changes CLOCK, BMAL1, CRY1, CRY2, PER1, PER2, PER3, and NPAS2 proteins in HCC patients. Hepatol Forum. 2023;4(3):108\u201317.","journal-title":"Hepatol Forum"},{"issue":"6","key":"6702_CR242","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41419-023-05879-w","volume":"14","author":"H Ren","year":"2023","unstructured":"Ren H, Chen Y, Zhu Z, Xia J, Liu S, Hu Y, et al. FOXO1 regulates Th17 cell-mediated hepatocellular carcinoma recurrence after hepatic ischemia-reperfusion injury. Cell Death Dis. 2023;14(6):1\u201314.","journal-title":"Cell Death Dis"},{"issue":"12","key":"6702_CR243","doi-asserted-by":"publisher","first-page":"2056","DOI":"10.4161\/auto.26398","volume":"9","author":"YF Peng","year":"2013","unstructured":"Peng YF, Shi YH, Ding ZB, Ke AW, Gu CY, Hui B, et al. Autophagy Inhibition suppresses pulmonary metastasis of HCC in mice via impairing Anoikis resistance and colonization of HCC cells. Autophagy. 2013;9(12):2056\u201368.","journal-title":"Autophagy"},{"issue":"5","key":"6702_CR244","doi-asserted-by":"publisher","first-page":"4002","DOI":"10.3892\/mmr.2015.3199","volume":"11","author":"C Yu","year":"2015","unstructured":"Yu C, Yang SL, Fang X, Jiang JX, Sun CY, Huang T. Hypoxia disrupts the expression levels of circadian rhythm genes in hepatocellular carcinoma. Mol Med Rep. 2015;11(5):4002\u20138.","journal-title":"Mol Med Rep"},{"issue":"4","key":"6702_CR245","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1038\/s42255-025-01265-2","volume":"7","author":"Y Liu","year":"2025","unstructured":"Liu Y, Dantas E, Ferrer M, Miao T, Qadiri M, Liu Y, et al. Hepatic gluconeogenesis and PDK3 upregulation drive cancer cachexia in flies and mice. Nat Metab. 2025;7(4):823\u201341.","journal-title":"Nat Metab"},{"key":"6702_CR246","doi-asserted-by":"crossref","unstructured":"Dong Z, Zhang G, Qu M, Gimple RC, Wu Q, Qiu Z, et al. Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock. Cancer Discov. 2019 Nov;9(11):1556\u201373.","DOI":"10.1158\/2159-8290.CD-19-0215"},{"issue":"4","key":"6702_CR247","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1021\/jacs.0c12280","volume":"143","author":"D Kolarski","year":"2021","unstructured":"Kolarski D, Miller S, Oshima T, Nagai Y, Aoki Y, Kobauri P, et al. Photopharmacological manipulation of mammalian CRY1 for regulation of the circadian clock. J Am Chem Soc. 2021;143(4):2078\u201387.","journal-title":"J Am Chem Soc"},{"issue":"3","key":"6702_CR248","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1021\/cb400752k","volume":"9","author":"SK Chun","year":"2014","unstructured":"Chun SK, Jang J, Chung S, Yun H, Kim NJ, Jung JW, et al. Identification and validation of Cryptochrome inhibitors that modulate the molecular circadian clock. ACS Chem Biol. 2014;9(3):703\u201310.","journal-title":"ACS Chem Biol"},{"issue":"2","key":"6702_CR249","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.bbrc.2015.09.103","volume":"467","author":"SK Chun","year":"2015","unstructured":"Chun SK, Chung S, Kim HD, Lee JH, Jang J, Kim J, et al. A synthetic Cryptochrome inhibitor induces anti-proliferative effects and increases chemosensitivity in human breast cancer cells. Biochem Biophys Res Commun. 2015;467(2):441\u20136.","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"6702_CR250","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1038\/hr.2014.157","volume":"38","author":"L Kovanen","year":"2015","unstructured":"Kovanen L, Donner K, Kaunisto M, Partonen T. CRY1, CRY2 and PRKCDBP genetic variants in metabolic syndrome. Hypertens Res. 2015;38(3):186\u201392.","journal-title":"Hypertens Res"},{"issue":"1","key":"6702_CR251","doi-asserted-by":"publisher","first-page":"20103","DOI":"10.1038\/s41598-021-99418-2","volume":"11","author":"SP Smieszek","year":"2021","unstructured":"Smieszek SP, Brzezynski JL, Kaden AR, Shinn JA, Wang J, Xiao C, et al. An observational study investigating the CRY1\u220611 variant associated with delayed sleep\u2013wake patterns and circadian metabolic output. Sci Rep. 2021;11(1):20103.","journal-title":"Sci Rep"},{"key":"6702_CR252","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/978-1-62703-068-7_4","volume":"933","author":"DD Belke","year":"2012","unstructured":"Belke DD, Severson DL. Diabetes in mice with Monogenic obesity: the db\/db mouse and its use in the study of cardiac consequences. Methods Mol Biol. 2012;933:47\u201357.","journal-title":"Methods Mol Biol"},{"issue":"12","key":"6702_CR253","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1038\/cr.2010.152","volume":"20","author":"M Hatori","year":"2010","unstructured":"Hatori M, Panda S. CRY links the circadian clock and CREB-mediated gluconeogenesis. Cell Res. 2010;20(12):1285\u20138.","journal-title":"Cell Res"},{"issue":"6","key":"6702_CR254","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1056\/NEJMra1802337","volume":"384","author":"R Allada","year":"2021","unstructured":"Allada R, Bass J. Circadian mechanisms in medicine. N Engl J Med. 2021;384(6):550\u201361.","journal-title":"N Engl J Med"},{"issue":"1","key":"6702_CR255","doi-asserted-by":"publisher","first-page":"18202","DOI":"10.1038\/s41598-024-68256-3","volume":"14","author":"Q Sun","year":"2024","unstructured":"Sun Q, Zheng S, Tang W, Wang X, Wang Q, Zhang R, et al. Prediction of lung adenocarcinoma prognosis and diagnosis with a novel model anchored in circadian clock-related genes. Sci Rep. 2024;14(1):18202.","journal-title":"Sci Rep"},{"issue":"20","key":"6702_CR256","doi-asserted-by":"publisher","first-page":"12541","DOI":"10.3390\/ijms232012541","volume":"23","author":"R Hammad","year":"2022","unstructured":"Hammad R, Aglan RB, Mohammed SA, Awad EA, elnasr, Elsaid MA, Bedair HM, et al. Cytotoxic T cell expression of Leukocyte-Associated Immunoglobulin-Like Receptor-1 (LAIR-1) in viral hepatitis C-Mediated hepatocellular carcinoma. Int J Mol Sci. 2022;23(20):12541.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"6702_CR257","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41392-024-01808-1","volume":"9","author":"Y Xia","year":"2024","unstructured":"Xia Y, Sun M, Huang H, Jin WL. Drug repurposing for cancer therapy. Sig Transduct Target Ther. 2024;9(1):1\u201333.","journal-title":"Sig Transduct Target Ther"},{"key":"6702_CR258","doi-asserted-by":"publisher","first-page":"950465","DOI":"10.3389\/fimmu.2023.950465","volume":"14","author":"A Ghaseminejad-Raeini","year":"2023","unstructured":"Ghaseminejad-Raeini A, Ghaderi A, Sharafi A, Nematollahi-Sani B, Moossavi M, Derakhshani A, et al. Immunomodulatory actions of vitamin D in various immune-related disorders: a comprehensive review. Front Immunol. 2023;14:950465.","journal-title":"Front Immunol"},{"issue":"13","key":"6702_CR259","doi-asserted-by":"publisher","first-page":"2830","DOI":"10.3390\/nu15132830","volume":"15","author":"YC Chen","year":"2023","unstructured":"Chen YC, Chiang YF, Lin YJ, Huang KC, Chen HY, Hamdy NM, et al. Effect of vitamin D supplementation on primary dysmenorrhea: A systematic review and Meta-Analysis of randomized clinical trials. Nutrients. 2023;15(13):2830.","journal-title":"Nutrients"},{"issue":"2","key":"6702_CR260","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1124\/pr.116.013441","volume":"69","author":"A Ballesta","year":"2017","unstructured":"Ballesta A, Innominato PF, Dallmann R, Rand DA, L\u00e9vi FA. Systems chronotherapeutics. Pharmacol Rev. 2017;69(2):161\u201399.","journal-title":"Pharmacol Rev"},{"key":"6702_CR261","doi-asserted-by":"publisher","first-page":"114045","DOI":"10.1016\/j.bcp.2020.114045","volume":"178","author":"D Dong","year":"2020","unstructured":"Dong D, Yang D, Lin L, Wang S, Wu B. Circadian rhythm in pharmacokinetics and its relevance to chronotherapy. Biochem Pharmacol. 2020;178:114045.","journal-title":"Biochem Pharmacol"},{"issue":"4","key":"6702_CR262","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/s40262-013-0121-2","volume":"53","author":"AH Salem","year":"2014","unstructured":"Salem AH, Koenig D, Carlson D. Pooled population Pharmacokinetic analysis of phase I, II and III studies of Linifanib in cancer patients. Clin Pharmacokinet. 2014;53(4):347\u201359.","journal-title":"Clin Pharmacokinet"},{"issue":"6","key":"6702_CR263","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1002\/cpt.3181","volume":"115","author":"FZ Marok","year":"2024","unstructured":"Marok FZ, Wojtyniak JG, Selzer D, Dallmann R, Swen JJ, Guchelaar HJ, et al. Personalized chronomodulated 5-Fluorouracil treatment: A Physiologically-Based Pharmacokinetic precision dosing approach for optimizing Cancer therapy. Clin Pharmacol Ther. 2024;115(6):1282\u201392.","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"6702_CR264","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.ejps.2008.10.024","volume":"36","author":"A Altinok","year":"2009","unstructured":"Altinok A, L\u00e9vi F, Goldbeter A. Identifying mechanisms of chronotolerance and chronoefficacy for the anticancer drugs 5-fluorouracil and oxaliplatin by computational modeling. Eur J Pharm Sci. 2009;36(1):20\u201338.","journal-title":"Eur J Pharm Sci"},{"issue":"21","key":"6702_CR265","first-page":"7277","volume":"63","author":"S Koyanagi","year":"2003","unstructured":"Koyanagi S, Kuramoto Y, Nakagawa H, Aramaki H, Ohdo S, Soeda S, et al. A molecular mechanism regulating circadian expression of vascular endothelial growth factor in tumor cells. Cancer Res. 2003;63(21):7277\u201383.","journal-title":"Cancer Res"},{"issue":"10","key":"6702_CR266","doi-asserted-by":"publisher","first-page":"2512","DOI":"10.1002\/ijc.33422","volume":"148","author":"PF Innominato","year":"2021","unstructured":"Innominato PF, Karabou\u00e9 A, Focan C, Chollet P, Giacchetti S, Bouchahda M, et al. Efficacy and safety of chronomodulated irinotecan, oxaliplatin, 5-fluorouracil and leucovorin combination as first- or second-line treatment against metastatic colorectal cancer: results from the international EORTC 05011 trial. Int J Cancer. 2021;148(10):2512\u201321.","journal-title":"Int J Cancer"},{"key":"6702_CR267","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1038\/s41467-020-20513-5","volume":"12","author":"AA Shafi","year":"2021","unstructured":"Shafi AA, McNair CM, McCann JJ, Alshalalfa M, Shostak A, Severson TM, et al. The circadian cryptochrome, CRY1, is a pro-tumorigenic factor that rhythmically modulates DNA repair. Nat Commun. 2021;12:401.","journal-title":"Nat Commun"},{"issue":"14","key":"6702_CR268","doi-asserted-by":"publisher","first-page":"2480","DOI":"10.7150\/jca.25213","volume":"9","author":"L Zhou","year":"2018","unstructured":"Zhou L, Yu Y, Sun S, Zhang T, Wang M. Cry 1 regulates the clock gene network and promotes proliferation and migration via the Akt\/P53\/P21 pathway in human osteosarcoma cells. J Cancer. 2018;9(14):2480\u201391.","journal-title":"J Cancer"},{"issue":"11","key":"6702_CR269","doi-asserted-by":"publisher","first-page":"4446","DOI":"10.1210\/jc.2013-2568","volume":"98","author":"T Mannic","year":"2013","unstructured":"Mannic T, Meyer P, Triponez F, Pusztaszeri M, Le Martelot G, Mariani O, et al. Circadian clock characteristics are altered in human thyroid malignant nodules. J Clin Endocrinol Metab. 2013;98(11):4446\u201356.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"6702_CR270","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1210\/jc.2017-02506","volume":"103","author":"SM Sadowski","year":"2018","unstructured":"Sadowski SM, Pusztaszeri M, Brulhart-Meynet MC, Petrenko V, De Vito C, Sobel J, et al. Identification of differential transcriptional patterns in primary and secondary hyperparathyroidism. J Clin Endocrinol Metab. 2018;103(6):2189\u201398.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"6702_CR271","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/j.molcel.2016.10.012","volume":"64","author":"AL Huber","year":"2016","unstructured":"Huber AL, Papp SJ, Chan AB, Henriksson E, Jordan SD, Kriebs A, et al. CRY2 and FBXL3 cooperatively degrade c-MYC. Mol Cell. 2016;64(4):774\u201389.","journal-title":"Mol Cell"},{"issue":"22","key":"6702_CR272","doi-asserted-by":"publisher","first-page":"9056","DOI":"10.18632\/aging.204386","volume":"14","author":"CC Wang","year":"2022","unstructured":"Wang CC, Lin WH, Ku SC, Shen WJ, Ta HDK, Anuraga G, et al. Circadian rhythm-related factors of PER and CRY family genes function as novel therapeutic targets and prognostic biomarkers in lung adenocarcinoma. Aging. 2022;14(22):9056\u201389.","journal-title":"Aging"},{"issue":"1","key":"6702_CR273","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s13277-011-0258-2","volume":"33","author":"CM Hsu","year":"2012","unstructured":"Hsu CM, Lin SF, Lu CT, Lin PM, Yang MY. Altered expression of circadian clock genes in head and neck squamous cell carcinoma. Tumour Biol. 2012;33(1):149\u201355.","journal-title":"Tumour Biol"},{"issue":"2","key":"6702_CR274","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1007\/s13277-012-0611-0","volume":"34","author":"Z Lengyel","year":"2013","unstructured":"Lengyel Z, Lovig C, Kommedal S, Keszthelyi R, Szekeres G, Batty\u00e1ni Z, et al. Altered expression patterns of clock gene mRNAs and clock proteins in human skin tumors. Tumour Biol. 2013;34(2):811\u20139.","journal-title":"Tumour Biol"},{"key":"6702_CR275","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s12943-016-0492-8","volume":"15","author":"G Mazzoccoli","year":"2016","unstructured":"Mazzoccoli G, Colangelo T, Panza A, Rubino R, De Cata A, Tiberio C, et al. Deregulated expression of Cryptochrome genes in human colorectal cancer. Mol Cancer. 2016;15:6.","journal-title":"Mol Cancer"},{"issue":"1","key":"6702_CR276","doi-asserted-by":"publisher","first-page":"6742","DOI":"10.1038\/s41467-022-34582-1","volume":"13","author":"S Gul","year":"2022","unstructured":"Gul S, Akyel YK, Gul ZM, Isin S, Ozcan O, Korkmaz T, et al. Discovery of a small molecule that selectively destabilizes Cryptochrome 1 and enhances life span in p53 knockout mice. Nat Commun. 2022;13(1):6742.","journal-title":"Nat Commun"},{"key":"6702_CR277","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.lfs.2018.03.022","volume":"200","author":"J Jang","year":"2018","unstructured":"Jang J, Chung S, Choi Y, Lim HY, Son Y, Chun SK, et al. The Cryptochrome inhibitor KS15 enhances E-box-mediated transcription by disrupting the feedback action of a circadian transcription-repressor complex. Life Sci. 2018;200:49\u201355.","journal-title":"Life Sci"},{"key":"6702_CR278","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.freeradbiomed.2024.03.015","volume":"217","author":"J Ma","year":"2024","unstructured":"Ma J, Chen S, Liu J, Liao Y, Li L, Wang CC, et al. Cryptochrome 1 regulates ovarian granulosa cell senescence through NCOA4-mediated ferritinophagy. Free Radic Biol Med. 2024;217:1\u201314.","journal-title":"Free Radic Biol Med"},{"issue":"9","key":"6702_CR279","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1016\/j.chembiol.2020.05.008","volume":"27","author":"S Miller","year":"2020","unstructured":"Miller S, Aikawa Y, Sugiyama A, Nagai Y, Hara A, Oshima T, et al. An Isoform-Selective modulator of Cryptochrome 1 regulates circadian rhythms in mammals. Cell Chem Biol. 2020;27(9):1192\u2013e11985.","journal-title":"Cell Chem Biol"},{"issue":"7","key":"6702_CR280","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1080\/07420528.2019.1606821","volume":"36","author":"XY Xiong","year":"2019","unstructured":"Xiong XY, Liang J, Xu YQ, Liu Y. The Tilapia collagen peptide mixture TY001 protects against LPS-induced inflammation, disruption of glucose metabolism, and aberrant expression of circadian clock genes in mice. Chronobiol Int. 2019;36(7):1013\u201323.","journal-title":"Chronobiol Int"},{"issue":"1","key":"6702_CR281","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/s41368-022-00207-y","volume":"14","author":"J Peng","year":"2022","unstructured":"Peng J, Zhao J, Tang Q, Wang J, Song W, Lu X, et al. Low intensity near-infrared light promotes bone regeneration via circadian clock protein Cryptochrome 1. Int J Oral Sci. 2022;14(1):53.","journal-title":"Int J Oral Sci"},{"issue":"6","key":"6702_CR282","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/s41589-020-0505-1","volume":"16","author":"S Miller","year":"2020","unstructured":"Miller S, Son YL, Aikawa Y, Makino E, Nagai Y, Srivastava A, et al. Isoform-selective regulation of mammalian Cryptochromes. Nat Chem Biol. 2020;16(6):676\u201385.","journal-title":"Nat Chem Biol"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-06702-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-025-06702-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-06702-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T14:48:15Z","timestamp":1750171695000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-025-06702-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,17]]},"references-count":282,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6702"],"URL":"https:\/\/doi.org\/10.1186\/s12967-025-06702-0","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,17]]},"assertion":[{"value":"13 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"669"}}